{"content":"<li class=\"n-box-item date-title\" data-end=\"1516683599\" data-start=\"1516597200\" data-txt=\"Monday, December 23, 2019\">Monday, January 22, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3324338\" data-ts=\"1516668148\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324338-stephens-removes-cbs-best-idea-amid-viacom-re-merger-talk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stephens removes CBS as best idea amid Viacom re-merger talk</a></h4><ul>   <li>CBS (NYSE:<a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a>) was dropped off the best idea list at Stephens as the firm sees Shari Redstone's current <a href=\"https://seekingalpha.com/news/3322709-viacom-cbs-jump-report-new-re-merger-pursuit\" target=\"_blank\">push to reunite the broadcaster</a> with Viacom (<a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a>, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a>) as harmful.</li>    <li>The Tiffany Network is an attractive M&amp;A target now, a status that would be threatened if it were part of Viacom, analyst Kyle Evans notes. And while the combo could see synergies, CBS investors would be less interested in that than in stand-alone CBS strengths, and Viacom's issues would remain unfixed.</li>    <li>He's downgraded CBS to Equal Weight and cut its price target to $64 from $72.</li>    <li>CBS shares <font color='green'>rose 0.9%</font> today to $58.25; <a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a> <font color='green'>+0.3%</font>; <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> <font color='green'>+1.7%</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3324338\" data-linked=\"Stephens removes CBS as best idea amid Viacom re-merger talk\" data-tweet=\"$CBS $VIAC $VIA - Stephens removes CBS as best idea amid Viacom re-merger talk https://seekingalpha.com/news/3324338-stephens-removes-cbs-best-idea-amid-viacom-re-merger-talk?source=tweet\" data-url=\"https://seekingalpha.com/news/3324338-stephens-removes-cbs-best-idea-amid-viacom-re-merger-talk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324335\" data-ts=\"1516665977\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUAN\" target=\"_blank\">NUAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324335-nuance-hits-seven-month-high-after-newsy-pre-release\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nuance hits seven-month high after newsy pre-release</a></h4><ul>   <li>Nuance Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/NUAN' title='Nuance Communications, Inc.'>NUAN</a>) <font color='green'>rose 9.8%</font> today to hit its highest point since June after announcing healthy preliminary results for its quarter this morning.</li>    <li>Along with indications that it's beating consensus on top and bottom lines, the company confirmed the exit of its CEO and laid out its focus in reorganizing its mobile division.</li>    <li>With activists clamoring, Chief Executive Paul Ricci will retire on or before March 31; the company's search committee is accelerating its process, and intends to name a new chief by then. Ricci won't be nominated for election to the board at the 2018 annual meeting.</li>    <li>Meanwhile, the company plans to merge its mobile communications service provider business into its Enterprise Division to consolidate focus on telecom, and will split off the Automotive business as its own reportable segment.</li>    <li>Bob Schassler, executive VP and GM of the Mobile division has resigned from the company; the newly merged Enterprise/Mobile CSP unit will report to Robert Weideman.</li>    <li>Automobile products accounted for about 13% of the company's revenue in fiscal 2017, and that should grow by double digits in the coming year, compared with 3% for the total company, Bloomberg notes.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3324089-nuance-plus-8-percent-prelim-q1-results-beat-prior-guidance-consensus\" target=\"_blank\">Nuance +8% on prelim Q1 results that beat prior guidance, consensus</a> (Jan. 22 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324335\" data-linked=\"Nuance hits seven-month high after newsy pre-release\" data-tweet=\"$NUAN - Nuance hits seven-month high after newsy pre-release https://seekingalpha.com/news/3324335-nuance-hits-seven-month-high-after-newsy-pre-release?source=tweet\" data-url=\"https://seekingalpha.com/news/3324335-nuance-hits-seven-month-high-after-newsy-pre-release\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324321\" data-ts=\"1516660681\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324321-after-hours-gainers-losers-1-22-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (1/22/2018)</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/RMD' title='ResMed Inc.'>RMD</a> <font color='green'>+11.8%</font>. <a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a> <font color='green'>+9.0%</font>. <a href='https://seekingalpha.com/symbol/FSLR' title='First Solar, Inc.'>FSLR</a> <font color='green'>+5.5%</font>. <a href='https://seekingalpha.com/symbol/ECR' title='Eclipse Resources'>ECR</a> <font color='green'>+3.0%</font>. <a href='https://seekingalpha.com/symbol/ROKU' title='Roku Inc.'>ROKU</a> <font color='green'>+2.9%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/HIFR' title='InfraREIT'>HIFR</a> <font color='red'>-3.5%</font>. <a href='https://seekingalpha.com/symbol/DQ' title='DAQO New Energy Corp.'>DQ</a> <font color='red'>-2.6%</font>. <a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a> <font color='red'>-2.4%</font>. <a href='https://seekingalpha.com/symbol/PCH' title='PotlatchDeltic Corp.'>PCH</a> <font color='red'>-2.3%</font>. <a href='https://seekingalpha.com/symbol/RARE' title='Ultragenyx Pharmaceutical Inc.'>RARE</a> <font color='red'>-2.0%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324321\" data-linked=\"After Hours Gainers / Losers (1/22/2018)\" data-tweet=\"$RMD $NFLX $FSLR - After Hours Gainers / Losers (1/22/2018) https://seekingalpha.com/news/3324321-after-hours-gainers-losers-1-22-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3324321-after-hours-gainers-losers-1-22-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324318\" data-ts=\"1516660181\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSLR\" target=\"_blank\">FSLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324318-first-solar-whirlpool-pop-on-trump-tariff-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Solar, Whirlpool pop on Trump tariff news</a></h4><ul>     <li>First Solar (NASDAQ:<a href='https://seekingalpha.com/symbol/FSLR' title='First Solar, Inc.'>FSLR</a>)&nbsp;<font color='green'>+6.2%</font> after-hours following the Trump administration's approval of <a href=\"https://ustr.gov/about-us/policy-offices/press-office/press-releases/2018/january/president-trump-approves-relief-us\" target=\"_blank\">tariffs as high as 30% on imported solar panels</a>, a bit lower than the 35% recommended last year by the U.S. International Trade Commission; FSLR is <a href=\"https://www.bloomberg.com/news/articles/2018-01-22/trump-taxes-solar-imports-in-biggest-blow-to-clean-energy-yet\" target=\"_blank\">seen gaining from the move</a> as costs for competing foreign panels rise.</li>     <li>The solar tariffs would last for four years and decline in increments of 5% from 30% at the start to 15% in the final year; the first 2.5 GW of imported solar cells will be exempt from the tariff.</li>     <li>Whirlpool (NYSE:<a href='https://seekingalpha.com/symbol/WHR' title='Whirlpool Corporation'>WHR</a>) <a href=\"https://www.marketwatch.com/story/first-solar-shares-jump-8-after-white-house-oks-tariffs-on-solar-panel-imports-2018-01-22\" target=\"_blank\">also is higher</a>, <font color='green'>+4%</font> as new tariffs on imported washing machines start at 20% and are imposed over three years, starting at 20% for the first 1.2M units of imported finished washers and 50% of all subsequent imports on year one.</li><li>Other potentially relevant tickers include <a href='https://seekingalpha.com/symbol/SPWR' title='SunPower Corporation'>SPWR</a>, <a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a>, <a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a>, <a href='https://seekingalpha.com/symbol/CAFD' title='8point3 Energy Partners LP'>CAFD</a>, <a href='https://seekingalpha.com/symbol/SOL' title='ReneSola Ltd.'>SOL</a>, <a href='https://seekingalpha.com/symbol/RUN' title='Sunrun'>RUN</a>, <a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a>, <a href='https://seekingalpha.com/symbol/JASO' title='JA Solar Holdings, Co., Ltd.'>JASO</a>, <a href='https://seekingalpha.com/symbol/YGE' title='Yingli Green Energy Holding Company Limited'>YGE</a>, <a href='https://seekingalpha.com/symbol/TERP' title='TerraForm Power, Inc.'>TERP</a>, <a href='https://seekingalpha.com/symbol/SEDG' title='SolarEdge Technologies'>SEDG</a>, <a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a></li><li>ETFs:&nbsp;<a href='https://seekingalpha.com/symbol/TAN' title='Invesco Solar Portfolio ETF'>TAN</a>, <a href='https://seekingalpha.com/symbol/KWT' title='VanEck Vectors Solar Energy ETF'>KWT</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3324318\" data-linked=\"First Solar, Whirlpool pop on Trump tariff news\" data-tweet=\"$FSLR $FSLR $WHR - First Solar, Whirlpool pop on Trump tariff news https://seekingalpha.com/news/3324318-first-solar-whirlpool-pop-on-trump-tariff-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3324318-first-solar-whirlpool-pop-on-trump-tariff-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>93&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324310\" data-ts=\"1516659050\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OKE\" target=\"_blank\">OKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324310-oneok-hikes-2018-financial-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ONEOK hikes 2018 financial guidance</a></h4><ul>     <li>ONEOK (NYSE:<a href='https://seekingalpha.com/symbol/OKE' title='ONEOK, Inc.'>OKE</a>)&nbsp;<font color='green'>+1.8%</font> after-hours as it forecasts FY 2018 net income of $955M-$1.155B and adjusted EBITDA of $2.215B-$2.415B, <a href=\"https://seekingalpha.com/pr/17052767-oneok-announces-2018-financial-guidance\" target=\"_blank\">nearly 20% higher</a> than previously announced 2017 guidance, driven primarily by anticipated natural gas and natural gas liquids volume increases in the STACK and SCOOP areas and Williston and  Permian basins.</li>     <li>OKE also says it continues to expect average annual dividend growth of 9%-11% through 2021 with annual dividend coverage greater than 1.2x; it expects 85%-95% of 2018  dividend payments to be a return of capital.</li>     <li>OKE sees FY 2018 adjusted EBITDA in its natural gas liquids segment of $1.3B-$1.43B, ~15% above 2017 guidance, with gathered NGLs of 850K-1M bbl/day and NGLs fractionated of 650K-725K bbl/day, up a respective 10% and 15% vs. 2017 guidance.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324310\" data-linked=\"ONEOK hikes 2018 financial guidance\" data-tweet=\"$OKE - ONEOK hikes 2018 financial guidance https://seekingalpha.com/news/3324310-oneok-hikes-2018-financial-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3324310-oneok-hikes-2018-financial-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324283\" data-ts=\"1516657338\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRBK\" target=\"_blank\">FRBK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324283-republic-first-bancorp-eps-of-0_05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Republic First Bancorp EPS of $0.05</a></h4><ul><li>Republic First Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/FRBK' title='Republic First Bancorp, Inc.'>FRBK</a>): Q4 EPS of $0.05 may not be comparable to consensus of $0.04.</li><li>Revenue of $21.9M (+29.2% Y/Y) <font color='red'>misses by $0.05M</font>.</li><li>Shares <font color='green'>+2.5%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17052824-republic-first-bancorp-inc-reports-80-percent-increase-net-income-deposit-growth-23-percent\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3324283\" data-linked=\"Republic First Bancorp EPS of $0.05\" data-tweet=\"$FRBK - Republic First Bancorp EPS of $0.05 https://seekingalpha.com/news/3324283-republic-first-bancorp-eps-of-0_05?source=tweet\" data-url=\"https://seekingalpha.com/news/3324283-republic-first-bancorp-eps-of-0_05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324275\" data-ts=\"1516656814\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMTD\" target=\"_blank\">AMTD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324275-ameritrade-up-2_4-after-strong-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ameritrade up 2.4% after strong outlook</a></h4><ul><li>Alongside FQ1 GAAP EPS at an inline $0.52 and non-GAAP EPS of $0.80, the full-year fiscal 2018 non-GAAP outlook is lifted to $2.55-$3.05 thanks to the new tax law. Estimates had been for $2.71.</li><li>Turning back to FQ1, net new client assets up 9%; average client trades per day of 726K up 49%. Company takes note of busy activity in blockchain- and cannabis-related names.</li><li><a href=\"http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.amtd.com%2Finvestor-relations%2Ffinancials-and-reports%2Fdefault.aspx&amp;esheet=51747060&amp;newsitemid=20180122006548&amp;lan=en-US&amp;anchor=Financial+Reports&amp;index=2&amp;md5=9536a4c36f549348d508ac0a6bdcdd5c\" target=\"_blank\">Conference call tomorrow at 8:30 ET</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3324261-td-ameritrade-gaap-eps-line-beats-revenue\" target=\"_blank\">TD Ameritrade GAAP EPS in-line, beats on revenue</a> (Jan. 22)</li><li><a href='https://seekingalpha.com/symbol/AMTD' title='TD Ameritrade Holding Corporation'>AMTD</a>&nbsp;<font color='green'>+2.4%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3324275\" data-linked=\"Ameritrade up 2.4% after strong outlook\" data-tweet=\"$AMTD - Ameritrade up 2.4% after strong outlook https://seekingalpha.com/news/3324275-ameritrade-up-2_4-after-strong-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3324275-ameritrade-up-2_4-after-strong-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324272\" data-ts=\"1516656660\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADBE\" target=\"_blank\">ADBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324272-adobe-raises-fy18-guidance-sharesplus-1_1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adobe raises FY18 guidance; shares +1.1%</a></h4><ul><li>Adobe Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Systems Incorporated'>ADBE</a>)<a href=\"https://www.reuters.com/article/us-adobe-outlook/adobe-lifts-earnings-forecast-on-tax-reform-boost-idUSKBN1FB2WW\" target=\"_blank\"> lifts</a> its FY18 EPS guidance to $6.20 from the prior forecast of $5.50.</li><li>               Adobe cites the recent U.S. tax laws since the company expects its effective tax rate to &ldquo;substantially&rdquo; decline.&nbsp;</li><li>               Adobe shares are&nbsp;<font color='green'>up 1.1%</font>&nbsp;aftermarket.&nbsp;&nbsp;</li></ul> &nbsp;<br /><div class=\"tiny-share-widget\" data-id=\"3324272\" data-linked=\"Adobe raises FY18 guidance; shares +1.1%\" data-tweet=\"$ADBE - Adobe raises FY18 guidance; shares +1.1% https://seekingalpha.com/news/3324272-adobe-raises-fy18-guidance-sharesplus-1_1?source=tweet\" data-url=\"https://seekingalpha.com/news/3324272-adobe-raises-fy18-guidance-sharesplus-1_1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324267\" data-ts=\"1516656327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORAN\" target=\"_blank\">ORAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324267-reuters-2017-merger-talks-orange-deutsche-telekom-failed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: 2017 merger talks between Orange, Deutsche Telekom failed</a></h4><ul>   <li>Orange (NYSE:<a href='https://seekingalpha.com/symbol/ORAN' title='Orange'>ORAN</a>) and Deutsche Telekom (<a href='https://seekingalpha.com/symbol/DTEGY' title='Deutsche Telekom AG ADR'>OTCQX:DTEGY</a>) <a href=\"https://finance.yahoo.com/news/orange-deutsche-telekom-shares-rise-142646014.html\" target=\"_blank\">discussed a Franco/German merger</a> between the two last year, Reuters reports, but the talks ended when the companies couldn't get onto equal footing.</li>    <li>\"It was studied by internal teams. But people quickly came to the conclusion that nothing could be done as Deutsche Telekom is far bigger than Orange,\" a source tells Reuters.</li>    <li>The French and German governments hold sizable stakes in the companies respectively. Politics complicated the completion of a deal, as did a purchasing JV the two have, and overlapping business in Poland, Slovakia and Romania.</li>    <li><a href='https://seekingalpha.com/symbol/ORAN' title='Orange'>ORAN</a> closed <font color='green'>up 2.9%</font>; <a href='https://seekingalpha.com/symbol/DTEGY' title='Deutsche Telekom AG ADR'>OTCQX:DTEGY</a> <font color='green'>up 2.5%</font> in U.S. trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324267\" data-linked=\"Reuters: 2017 merger talks between Orange, Deutsche Telekom failed\" data-tweet=\"$ORAN $ORAN $DTEGY - Reuters: 2017 merger talks between Orange, Deutsche Telekom failed https://seekingalpha.com/news/3324267-reuters-2017-merger-talks-orange-deutsche-telekom-failed?source=tweet\" data-url=\"https://seekingalpha.com/news/3324267-reuters-2017-merger-talks-orange-deutsche-telekom-failed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324261\" data-ts=\"1516655961\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMTD\" target=\"_blank\">AMTD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324261-td-ameritrade-gaap-eps-in-line-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TD Ameritrade GAAP EPS in-line, beats on revenue</a></h4><ul><li>TD Ameritrade (NASDAQ:<a href='https://seekingalpha.com/symbol/AMTD' title='TD Ameritrade Holding Corporation'>AMTD</a>): Q1 GAAP&nbsp;EPS of $0.52 in-line.</li><li>Revenue of $1.26B (+46.7% Y/Y) <font color='green'>beats by $60M</font>.</li><li>Shares <font color='green'>+3.7%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17052782-investor-engagement-scottrade-drive-strong-first-quarter-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3324261\" data-linked=\"TD Ameritrade GAAP EPS in-line, beats on revenue\" data-tweet=\"$AMTD - TD Ameritrade GAAP EPS in-line, beats on revenue https://seekingalpha.com/news/3324261-td-ameritrade-gaap-eps-in-line-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3324261-td-ameritrade-gaap-eps-in-line-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324256\" data-ts=\"1516655821\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324256-netflix-smashes-subscriber-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix smashes subscriber estimates</a></h4><ul>     <li>Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) jumps to a new all-time high after posting Q4 numbers.</li>     <li>The company reported 1.98M domestic streaming additions vs. 1.29M consensus and 1.25M guidance.</li>     <li>International streaming additions were up to 6.36M to top the 5.05M expected by both analysts and the company.</li>     <li>Total streamings adds were 8.33M for the quarter vs. 6.34M consensus.</li>     <li>Q4 U.S. streaming contribution margin fell 140 bps Q/Q to 34.4% vs. 34.4% expected. The international contribution margin rate was 8.7% vs. 7.4% expected.</li>     <li>The company's operating margin improved 50 bps Q/Q to 7.5%.</li>     <li>Netflix on cash flow: \"In Q4, free cash flow amounted to -$524 million, bringing full year 2017 FCF to -$2.0 billion, at the lower end of the -$2.0 to -$2.5 billion range we had previously indicated. This was largely due to the timing of content payments, which will now occur in 2018.\"</li>     <li>Netflix on content spending: \"With greater than expected member growth (resulting in more revenue), we now plan to spend $7.5-$8.0 billion on content on a P&amp;L basis in 2018.\"</li>     <li>Looking ahead, Netflix expects Q1 domestic streaming adds of 1.45M and international streaming additions of 4.90M.</li>     <li>Source: <a href=\"https://ir.netflix.com/static-files/0c060a3f-d903-4eb9-bde6-bf3e58761712\" target=\"_blank\">Netflix Q4 shareholder letter</a></li>     <li>Upcoming: <a href=\"https://ir.netflix.com/investor-events\" target=\"_blank\">Netflix earnings call webcast</a></li>     <li>NFLX <font color='green'>+9.42%</font> AH to $249.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324256\" data-linked=\"Netflix smashes subscriber estimates\" data-tweet=\"$NFLX - Netflix smashes subscriber estimates https://seekingalpha.com/news/3324256-netflix-smashes-subscriber-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3324256-netflix-smashes-subscriber-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>190&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324247\" data-ts=\"1516655438\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RMD\" target=\"_blank\">RMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324247-resmed-beats-0_22-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ResMed beats by $0.22, beats on revenue</a></h4><ul><li>ResMed (NYSE:<a href='https://seekingalpha.com/symbol/RMD' title='ResMed Inc.'>RMD</a>): Q2 EPS of $1.00 <font color='green'>beats by $0.22</font>.</li><li>Revenue of $601.27M (+13.4% Y/Y) <font color='green'>beats by $20.95M</font>.</li><li>Shares <font color='green'>+3.4%</font>.</li><li><a href='https://seekingalpha.com/pr/17052720-resmed-inc-announces-results-second-quarter-fiscal-year-2018'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3324247\" data-linked=\"ResMed beats by $0.22, beats on revenue\" data-tweet=\"$RMD - ResMed beats by $0.22, beats on revenue https://seekingalpha.com/news/3324247-resmed-beats-0_22-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3324247-resmed-beats-0_22-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324243\" data-ts=\"1516655289\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324243-netflix-eps-in-line-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix EPS in-line, beats on revenue</a></h4><ul><li>Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>): Q4 EPS of $0.41 in-line.</li><li>Revenue of $3.29B (+32.7% Y/Y) <font color='green'>beats by $10M</font>.</li><li>Shares <font color='green'>+6.4%</font>.</li><li><a href=\"https://ir.netflix.com/static-files/0c060a3f-d903-4eb9-bde6-bf3e58761712\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3324243\" data-linked=\"Netflix EPS in-line, beats on revenue\" data-tweet=\"$NFLX - Netflix EPS in-line, beats on revenue https://seekingalpha.com/news/3324243-netflix-eps-in-line-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3324243-netflix-eps-in-line-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>69&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324230\" data-ts=\"1516653722\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAL\" target=\"_blank\">HAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324230-halliburtonplus-6-worst-may-be-over-for-oilfield-service-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Halliburton +6% as worst may be over for oilfield service business</a></h4><ul>     <li>Halliburton (<a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a> <font color='green'>+6.3%</font>) surges to its highest level in nearly a year following better than expected <a href=\"https://seekingalpha.com/news/3324048-halliburton-beats-0_07-beats-revenue\" target=\"_blank\">Q4 results</a> and an <a href=\"https://seekingalpha.com/news/3324070-halliburton-plus-3-percent-strong-q4-beat-optimistic-outlook\" target=\"_blank\">upbeat view</a> of the health of the U.S. oil industry given the rise in oil prices and increased drilling.</li>     <li>&ldquo;I am very excited about the way 2018 is shaping up,&rdquo; HAL&nbsp;CEO said during today&rsquo;s earnings conference call. &ldquo;North American unconventional activity should be very busy.&rdquo;</li>     <li>HAL says it is essentially <a href=\"https://www.bloomberg.com/gadfly/articles/2018-01-22/halliburton-earnings-america-makes-it-great-again\" target=\"_blank\">sold out in terms of its fracking fleet</a> in a market that is short of supply, and CEO&nbsp;Jeff Miller noted that the company has&nbsp;\"less equipment in the field than we did at our peak in 2014.\"</li>     <li>&ldquo;The big takeaway is that [SLB] conveyed an <a href=\"https://www.reuters.com/article/us-halliburton-results/halliburton-upbeat-on-2018-as-oil-recovery-spreads-idUSKBN1FB1HL?il=0\" target=\"_blank\">unequivocally constructive outlook</a> for the industry in 2018,&rdquo; says Simmons analyst Bill Herbert, noting the company&rsquo;s expectation that its North American margins will climb to ~20% this year after coming in at the mid-teens last year.</li>     <li>Guggenheim <a href=\"https://www.barrons.com/articles/halliburtons-earnings-are-so-good-theyre-giving-oil-services-stocks-a-boost-1516640862\" target=\"_blank\">upgrades</a> HAL to Buy from Neutral with a $75 price target, reflecting its belief that the U.S. fracking market will stay tight this year, supporting pricing, with HAL set to benefit from lower corporate taxes and the addition of new fleets of equipment.</li>     <li>HAL's strong showing gives hope that the worst is over for oilfield servicers: <a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a> <font color='green'>+4.3%</font>, <a href='https://seekingalpha.com/symbol/NOV' title='National Oilwell Varco, Inc.'>NOV</a> <font color='green'>+2%</font>, <a href='https://seekingalpha.com/symbol/BHGE' title='Baker Hughes, a GE company'>BHGE</a> <font color='green'>+2.5%</font>, <a href='https://seekingalpha.com/symbol/SPN' title='Superior Energy Services, Inc.'>SPN</a> <font color='green'>+4.2%</font>, <a href='https://seekingalpha.com/symbol/FRAC' title='Keane Group'>FRAC</a> <font color='green'>+2%</font>, <a href='https://seekingalpha.com/symbol/DRQ' title='Dril-Quip, Inc.'>DRQ</a> <font color='green'>+1.5%</font>, <a href='https://seekingalpha.com/symbol/FET' title='Forum Energy Technologies'>FET</a> <font color='green'>+2.6%</font>, <a href='https://seekingalpha.com/symbol/OIS' title='Oil States International Inc.'>OIS</a> <font color='green'>+1.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324230\" data-linked=\"Halliburton +6% as worst may be over for oilfield service business\" data-tweet=\"$HAL $HAL $SLB - Halliburton +6% as worst may be over for oilfield service business https://seekingalpha.com/news/3324230-halliburtonplus-6-worst-may-be-over-for-oilfield-service-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3324230-halliburtonplus-6-worst-may-be-over-for-oilfield-service-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324227\" data-ts=\"1516653405\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LOW\" target=\"_blank\">LOW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324227-lowes-jumps-to-fresh-all-time-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lowe&#39;s jumps to fresh all-time high</a></h4><ul> <li>Lowe's (NYSE:<a href='https://seekingalpha.com/symbol/LOW' title='Lowe&#39;s Companies, Inc.'>LOW</a>) is <font color='green'>up 1.65%</font> after the retailer <a href=\"https://www.barrons.com/articles/why-lowes-is-heading-higher-1516651186\" target=\"_blank\">catches</a> the attention of two Wall Street firms today.</li> <li>Morgan Stanley backed up its Overweight rating on Lowe's and calls the home improvement chain one of its top picks for 2018. MS thinks a lot of the tax reform savings will be funneled to shareholders.</li> <li>Bernstein moved up two notches to an Outperform rating after having Lowe's lined up at Underperform. The PT is taken all the way up to $125 with many of prior hurdles for Lowe's now seen as cleared.</li> <li>Lowe's hit an all-time intraday high of $107.36 earlier.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324227\" data-linked=\"Lowe&#39;s jumps to fresh all-time high\" data-tweet=\"$LOW - Lowe&#39;s jumps to fresh all-time high https://seekingalpha.com/news/3324227-lowes-jumps-to-fresh-all-time-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3324227-lowes-jumps-to-fresh-all-time-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324223\" data-ts=\"1516651392\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TECK\" target=\"_blank\">TECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324223-explosion-tecks-elkview-mine-hit-production-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Explosion at Teck&#39;s Elkview mine could hit production, analyst says</a></h4><ul>     <li>Teck Resources (<a href='https://seekingalpha.com/symbol/TECK' title='Teck Resources Limited'>TECK</a> <font color='red'>-1.4%</font>)&nbsp;is lower following news late Friday that a &ldquo;<a href=\"https://seekingalpha.com/pr/17051661-teck-announces-elkview-incident\" target=\"_blank\">significant pressure event</a>&rdquo; occurred at the dryer at its Elkview coal mine in British Columbia.</li><li>CIBC analysts say the incident could <a href=\"http://www.timescolonist.com/explosion-knocks-out-drying-complex-at-teck-coal-mine-raising-safety-concerns-1.23151306\" target=\"_blank\">cut Teck's 2018 metallurgical coal production by 13%</a> to 23.7M metric tons while mining and  logistics costs likely would rise by ~$1/ton and capital  spending could increase by $100M.</li><li>Teck says Elkview continues to operate at a reduced production rate using unaffected facilities at the mine, and it is too soon to estimate the extent  of any downtime or loss of production due to incident.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324223\" data-linked=\"Explosion at Teck&#39;s Elkview mine could hit production, analyst says\" data-tweet=\"$TECK - Explosion at Teck&#39;s Elkview mine could hit production, analyst says https://seekingalpha.com/news/3324223-explosion-tecks-elkview-mine-hit-production-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3324223-explosion-tecks-elkview-mine-hit-production-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324221\" data-ts=\"1516650953\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324221-technology-top-gainers-losers-of-2_55-pm-1-22-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2.55 pm (1/22/18)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LTRX' title='Lantronix, Inc.'>LTRX</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/INSG' title='Inseego Corp.'>INSG</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/NUAN' title='Nuance Communications, Inc.'>NUAN</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SANM' title='Sanmina Corp'>SANM</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/SPI' title='SPI Energy Co., Ltd.'>SPI</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/NCTY' title='The9 Limited'>NCTY</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/IIVI' title='II-VI Incorporated'>IIVI</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324221\" data-linked=\"Technology - Top Gainers / Losers as of 2.55 pm (1/22/18)\" data-tweet=\"$LTRX $MYSZ $INSG - Technology - Top Gainers / Losers as of 2.55 pm (1/22/18) https://seekingalpha.com/news/3324221-technology-top-gainers-losers-of-2_55-pm-1-22-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3324221-technology-top-gainers-losers-of-2_55-pm-1-22-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324213\" data-ts=\"1516649314\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTDR\" target=\"_blank\">MTDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324213-matadors-midstream-jv-to-partner-plains-for-delaware-basin-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Matador&#39;s midstream JV to partner with Plains for Delaware Basin deal</a></h4><ul>     <li>Matador Resources (<a href='https://seekingalpha.com/symbol/MTDR' title='Matador Resources'>MTDR</a> <font color='green'>+3.2%</font>) is higher after announcing a <a href=\"https://seekingalpha.com/pr/17051840-matador-resources-company-announces-strategic-relationship-plains-american-pipeline-rustler\" target=\"_blank\">new strategic partnership</a> with Plains All American Pipeline (<a href='https://seekingalpha.com/symbol/PAA' title='Plains All American Pipeline, L.P.'>PAA</a> <font color='green'>+2.6%</font>) to gather and transport crude oil for MTDR and other producers in the Rustler Breaks asset area in New Mexico.</li>     <li>The agreement also includes a joint tariff arrangement to offer third-party producers located within a joint development area of ~400K acres in crude oil transportation services from the wellhead to Midland, Tex., with access to other end markets, such as  Cushing, Okla., and the Gulf Coast.</li><li>With Delaware Basin transportation costs rising, MTDR says it expects       to amass \"substantial\" savings by transporting increasing volumes of its oil by pipeline.</li>     <li>Plains is expecting to complete a mainline extension from its current long-haul pipeline system in Texas during Q2 or Q3.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324213\" data-linked=\"Matador&#39;s midstream JV to partner with Plains for Delaware Basin deal\" data-tweet=\"$MTDR $MTDR $PAA - Matador&#39;s midstream JV to partner with Plains for Delaware Basin deal https://seekingalpha.com/news/3324213-matadors-midstream-jv-to-partner-plains-for-delaware-basin-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3324213-matadors-midstream-jv-to-partner-plains-for-delaware-basin-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324209\" data-ts=\"1516648026\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LTBR\" target=\"_blank\">LTBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324209-lightbridge-nearly-doubles-on-additional-u-s-patent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lightbridge nearly doubles on additional U.S. patent</a></h4><ul>     <li>Lightbridge (<a href='https://seekingalpha.com/symbol/LTBR' title='Lightbridge Corp'>LTBR</a> <font color='green'>+92.5%</font>) shares skyrocket to a two-year high after saying it received a notice of allowance for <a href=\"https://seekingalpha.com/pr/17051946-lightbridge-receives-u-s-approval-key-patent-innovative-fuel-design\" target=\"_blank\">patenting its metallic nuclear fuel assembly design</a>.</li><li>LTBR says the decision by the U.S. patent office extends its patent portfolio coverage to its entire design for metallic fuel assemblies for Western-type pressurized water reactors, which comprise two-thirds of operating power plants worldwide.</li><li>LTBR also says it is finalizing a joint venture with nuclear components and reactor services company Framatome to commercialize metallic fuel for nuclear plants around the world.</li></ul><div class=\"tiny-share-widget\" data-id=\"3324209\" data-linked=\"Lightbridge nearly doubles on additional U.S. patent\" data-tweet=\"$LTBR - Lightbridge nearly doubles on additional U.S. patent https://seekingalpha.com/news/3324209-lightbridge-nearly-doubles-on-additional-u-s-patent?source=tweet\" data-url=\"https://seekingalpha.com/news/3324209-lightbridge-nearly-doubles-on-additional-u-s-patent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324208\" data-ts=\"1516647670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324208-energy-materials-top-gainers-losers-of-2-00-pm-1-22-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm (1/22/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LTBR' title='Lightbridge Corp'>LTBR</a> <font color='green'>+97%</font>. <a href='https://seekingalpha.com/symbol/BRN' title='Barnwell Industries, Inc'>BRN</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/HCLP' title='Hi-Crush Partners LP'>HCLP</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/PQ' title='PetroQuest Energy Inc.'>PQ</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/SXCP' title='SunCoke Energy Partners'>SXCP</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HGT-OLD' title='Hugoton Royalty Trust'>HGT-OLD</a> <font color='red'>-41%</font>. <a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/MNGA' title='MagneGas Corporation'>MNGA</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/USAU' title='U.S. Gold Corp.'>USAU</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/YTEN' title='Yield10 Bioscience, Inc.'>YTEN</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3324208\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm (1/22/2018)\" data-tweet=\"$LTBR $BRN $HCR - Energy/Materials - Top Gainers / Losers as of 2:00 pm (1/22/2018) https://seekingalpha.com/news/3324208-energy-materials-top-gainers-losers-of-2-00-pm-1-22-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3324208-energy-materials-top-gainers-losers-of-2-00-pm-1-22-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324211\" data-ts=\"1516647002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LFIN\" target=\"_blank\">LFIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324211-longfin-launches-commercial-ziddu-smart-contracts-on-ethereum-blockchain-sharesplus-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Longfin launches commercial ziddu smart contracts on Ethereum Blockchain; Shares +7%</a></h4><ul>     <li>Longfin (<a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='green'>+7.3%</font>) has announced that its Ziddu Smart Contracts are commercially available on the Ethereum blockchain.</li>     <li>Ziddu.com is an ERC 20 Ethereum-Blockchain-empowered Smart Contract provider, and it is currently the only marketplace for decentralized smart contracts.</li>     <li>Ziddu Smart Contracts are available for Trade Finance and FX markets.</li>     <li>Longfin is preparing to launch Smart Contracts for bullion financing by Q218.</li>     <li>The company has subsequent plans to make the Contracts available for peer-to-peer lending, warehouse financing, structured products, and FX/OTC derivative segments.</li>     <li>&ldquo;It will take some time for the technology to develop to maturity and for the market to shake-out. In the meantime, Longfin has developed a high degree of interest and effort into the development of Smart Contracts. We see them as a critical component in distributed ledgers for pre-&amp;-post settlements, and there is an opportunity in creating a ripe scenario for disruption.&rdquo; Says Venkat Meenavalli, Chairman of Longfin.</li><li><a href=\"https://seekingalpha.com/pr/17052144-longfin-corp-launches-commercial-ziddu-smart-contracts-ethereum-blockchain\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3324211\" data-linked=\"Longfin launches commercial ziddu smart contracts on Ethereum Blockchain; Shares +7%\" data-tweet=\"$LFIN - Longfin launches commercial ziddu smart contracts on Ethereum Blockchain; Shares +7% https://seekingalpha.com/news/3324211-longfin-launches-commercial-ziddu-smart-contracts-on-ethereum-blockchain-sharesplus-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3324211-longfin-launches-commercial-ziddu-smart-contracts-on-ethereum-blockchain-sharesplus-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324204\" data-ts=\"1516645942\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVCN\" target=\"_blank\">NVCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324204-new-chief-neovasc-shares-up-19\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New chief at Neovasc; shares up 19%</a></h4><ul><li>Neovasc (<a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a> <font color='green'>+19%</font>) <a href=\"https://seekingalpha.com/pr/17051899-fred-colen-appointed-chief-executive-officer-neovasc-inc\" target=\"_blank\">appoints </a>Fred Colen as President &amp; CEO effective immediately. He succeeds Alexei Marko who will continue to serve as a board member.</li><li>Previously, Mr. Colen was President &amp; CEO at BeneChill. Before that, he held senior positions at Boston Scientific.</li></ul><div class=\"tiny-share-widget\" data-id=\"3324204\" data-linked=\"New chief at Neovasc; shares up 19%\" data-tweet=\"$NVCN - New chief at Neovasc; shares up 19% https://seekingalpha.com/news/3324204-new-chief-neovasc-shares-up-19?source=tweet\" data-url=\"https://seekingalpha.com/news/3324204-new-chief-neovasc-shares-up-19\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324202\" data-ts=\"1516645914\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324202-report-cbs-nbc-fox-bid-for-thursday-nfl-games\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: CBS, NBC, Fox bid for Thursday NFL games</a></h4><ul>   <li>This year's Thursday-night football TV rights holders CBS (<a href=\"http://seekingalpha.com/symbol/CBS\" target=\"_blank\">CBS</a> <font color='red'>-0.7%</font>) and NBC (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='green'>+0.7%</font>) were <a href=\"http://www.sportsbusinessdaily.com/Daily/Issues/2018/01/22/Media/TNF.aspx?ana=SBD%20Email\" target=\"_blank\">two of the three companies to bid for Thursdays in 2018</a>, Sports Business Daily reports.</li>    <li>They were joined only by Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='green'>+1.8%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+1.7%</font>) in a year expected to see a decline in the fees paid. Last week, Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color='green'>+1.6%</font>) elected to <a href=\"https://seekingalpha.com/news/3323944-bloomberg-facebook-bid-thursday-night-nfl\" target=\"_blank\">sit out bidding</a> for streaming rights.</li>    <li>CBS and NBC reportedly submitted bids less than they paid for 2017 (a combined $450M) after losing money on the deal this year amid waning advertiser interest.</li>    <li>Meanwhile, the programming could change homes as Fox is reported to have put in a higher-than-current bid.</li>    <li>Skipping out on Thursday NFL TV bidding: ESPN/ABC (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color='green'>+0.4%</font>) and (for the first time) Turner (<a href=\"http://seekingalpha.com/symbol/TWX\" target=\"_blank\">TWX</a> <font color='green'>+0.2%</font>) -- though the NFL has made it clear it won't sell Thursdays to a cable channel.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324202\" data-linked=\"Report: CBS, NBC, Fox bid for Thursday NFL games\" data-tweet=\"$FOX $FOX $FOXA - Report: CBS, NBC, Fox bid for Thursday NFL games https://seekingalpha.com/news/3324202-report-cbs-nbc-fox-bid-for-thursday-nfl-games?source=tweet\" data-url=\"https://seekingalpha.com/news/3324202-report-cbs-nbc-fox-bid-for-thursday-nfl-games\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324201\" data-ts=\"1516645640\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INO\" target=\"_blank\">INO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324201-inovios-investigational-flu-vaccine-shows-broad-protection-in-preclinical-studies-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inovio&#39;s investigational flu vaccine shows broad protection in preclinical studies; shares up 4%</a></h4><ul><li>Inovio Pharmaceuticals (<a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color='green'>+4.2%</font>) is up on almost double normal volume on the heels of its <a href=\"https://seekingalpha.com/pr/17052029-inovio-pharmaceuticals-published-universal-flu-vaccine-data-demonstrates-protective-responses\" target=\"_blank\">announcement </a>of encouraging preclinical data on its universal flu vaccine.</li><li>In a range of animal models, the vaccine, a collection of synthetic DNA antigens, generated broad protective antibody responses against all major deadly strains of H1 influenza viruses from the past 100 years, including the Spanish Flu bug from 1918. The vaccine protected 100% of immunized ferrets from a lethal virus challenge.</li><li>The company says the DNA antigens are easy to formulate and can be developed to include seasonal vaccine changes thereby maintaining protection, adding that the immune responses were generated using its skin delivery system.</li></ul><div class=\"tiny-share-widget\" data-id=\"3324201\" data-linked=\"Inovio&#39;s investigational flu vaccine shows broad protection in preclinical studies; shares up 4%\" data-tweet=\"$INO - Inovio&#39;s investigational flu vaccine shows broad protection in preclinical studies; shares up 4% https://seekingalpha.com/news/3324201-inovios-investigational-flu-vaccine-shows-broad-protection-in-preclinical-studies-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3324201-inovios-investigational-flu-vaccine-shows-broad-protection-in-preclinical-studies-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324199\" data-ts=\"1516645264\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324199-jumanji-now-one-of-sonys-best-ever-film-performers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&#39;Jumanji&#39; now one of Sony&#39;s best-ever film performers</a></h4><ul>   <li>It was another week at the top for top box-office draw Dwayne Johnson and <i>Jumanji: Welcome to the Jungle,</i> which outgrossed another two openings to lead for the third straight week.</li>    <li>With $20M in its fifth week of release, the film becomes one of Sony's (<a href=\"http://seekingalpha.com/symbol/SNE\" target=\"_blank\">SNE</a> <font color='green'>+1.2%</font>) best-performing releases ever. It's grossed $317M domestically, passing <i>Skyfall</i> and making it Sony's No. 5 performer on that all-time chart. And it's drawn a worldwide total of $767.8M.</li>    <li>It topped the $16.5M grossed by war film <i>12 Strong</i> (<a href=\"http://seekingalpha.com/symbol/TWX\" target=\"_blank\">TWX</a> <font color='green'>+0.2%</font>), and $15.3M from fellow newcomer (and Federal Reserve theft movie!) <i>Den of Thieves</i> &#40;STX&#41;. It's also the first film not to open atop the box office to go on to top $300M (thanks to a release against <i>Star Wars: The Last Jedi).</i></li>    <li>A pair of Fox releases (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='green'>+1.9%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+1.8%</font>) rounded out the top five: <i>The Post</i> at No. 4 with $12.15M, and <i>The Greatest Showman</i> with $11M (hitting $113.5M cumulative).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324199\" data-linked=\"&#39;Jumanji&#39; now one of Sony&#39;s best-ever film performers\" data-tweet=\"$FOX $FOX $FOXA - &#39;Jumanji&#39; now one of Sony&#39;s best-ever film performers https://seekingalpha.com/news/3324199-jumanji-now-one-of-sonys-best-ever-film-performers?source=tweet\" data-url=\"https://seekingalpha.com/news/3324199-jumanji-now-one-of-sonys-best-ever-film-performers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324196\" data-ts=\"1516644057\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324196-financials-top-5-gainers-losers-of-1-00-pm-1-22-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM (1/22/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/VR' title='Validus Holdings, Ltd.'>VR</a> <font color='green'>+44%</font>. <a href='https://seekingalpha.com/symbol/AHL' title='Aspen Insurance Holdings Limited'>AHL</a> <font color='green'>+10%</font>.<a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/AXS' title='Axis Capital Holdings Limited'>AXS</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RCG' title='RENN Global Entrepreneurs Fund'>RCG</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/HRTG' title='Heritage Insurance Holdings, Inc.'>HRTG</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/LCNB' title='LCNB Corp.'>LCNB</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3324196\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM (1/22/2018)\" data-tweet=\"$VR $AHL $FRSX - Financials - Top 5 Gainers / Losers as of 1:00 PM (1/22/2018) https://seekingalpha.com/news/3324196-financials-top-5-gainers-losers-of-1-00-pm-1-22-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3324196-financials-top-5-gainers-losers-of-1-00-pm-1-22-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324190\" data-ts=\"1516643442\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ULTA\" target=\"_blank\">ULTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324190-piper-jaffray-cautious-on-ulta-beauty\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper Jaffray cautious on Ulta Beauty</a></h4><ul> <li>Piper Jaffray warns that Ulta Beauty (<a href='https://seekingalpha.com/symbol/ULTA' title='Ulta Beauty, Inc.'>ULTA</a> <font color='red'>-4.1%</font>) could sees some disruption as the selection of brands offered at stores is reset.</li> <li>The firm also thinks the new mix of products could pressure margin and warns that the Drew Barrymore Flower Beauty launch might fall short of hyped-up expectations.</li> <li>PJ has a Neutral rating on Ulta and a price target of $230.</li> <li>Sources: CNBC and Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324190\" data-linked=\"Piper Jaffray cautious on Ulta Beauty\" data-tweet=\"$ULTA - Piper Jaffray cautious on Ulta Beauty https://seekingalpha.com/news/3324190-piper-jaffray-cautious-on-ulta-beauty?source=tweet\" data-url=\"https://seekingalpha.com/news/3324190-piper-jaffray-cautious-on-ulta-beauty\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324188\" data-ts=\"1516643107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324188-midday-gainers-losers-1-22-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (1/22/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LTBR' title='Lightbridge Corp'>LTBR</a> <font color='green'>+97%</font>. <a href='https://seekingalpha.com/symbol/BIVV' title='Bioverativ Inc.'>BIVV</a> <font color='green'>+62%</font>. <a href='https://seekingalpha.com/symbol/VR' title='Validus Holdings, Ltd.'>VR</a> <font color='green'>+44%</font>. <a href='https://seekingalpha.com/symbol/JUNO' title='Juno Therapeutics'>JUNO</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/HTGM' title='HTG Molecular Diagnostics'>HTGM</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/VNRX' title='VolitionRX Ltd'>VNRX</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/ZIOP' title='ZIOPHARM Oncology, Inc.'>ZIOP</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/NYMX' title='Nymox Pharmaceutical Corporation'>NYMX</a> <font color='green'>+16%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HGT-OLD' title='Hugoton Royalty Trust'>HGT-OLD</a> <font color='red'>-41%</font>. <a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/VICL' title='Vical Incorporated'>VICL</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/IDRA' title='Idera Pharmaceuticals, Inc.'>IDRA</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/SANM' title='Sanmina Corp'>SANM</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/FORD' title='Forward Industries, Inc.'>FORD</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/NCTY' title='The9 Limited'>NCTY</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics'>ONTX</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/MNGA' title='MagneGas Corporation'>MNGA</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324188\" data-linked=\"Midday Gainers / Losers (1/22/2018)\" data-tweet=\"$LTBR $BIVV $VR - Midday Gainers / Losers (1/22/2018) https://seekingalpha.com/news/3324188-midday-gainers-losers-1-22-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3324188-midday-gainers-losers-1-22-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324183\" data-ts=\"1516642235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGND\" target=\"_blank\">LGND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324183-ligand-pharma-out-licenses-omniab-platform-to-ferring-pharma-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ligand Pharma out-licenses OmniAb platform to Ferring Pharma; shares up 3%</a></h4><ul><li>Thinly traded Ligand Pharmaceuticals (<a href='https://seekingalpha.com/symbol/LGND' title='Ligand Pharmaceuticals Incorporated'>LGND</a> <font color='green'>+3.2%</font>) is up on modestly higher volume in response to its <a href=\"https://seekingalpha.com/pr/17052199-ligand-enters-worldwide-omniab-platform-license-agreement-ferring-pharmaceuticals\" target=\"_blank\">announcement </a>that it has out-licensed its OmniAb antibody discovery platform to Ferring Pharmaceuticals.</li><li>Under the terms of the agreement, Ligand will receive annual platform access payments, development and regulatory milestones and tiered royalties on net commercial sales of related products. Specific financial terms are not disclosed.</li><li><a href=\"https://www.ligand.com/technologies/omniab\" target=\"_blank\">OmniAb </a>is a three-species (mouse, rat, chicken) transgenic animal platform consisting of four distinct technologies for producing mono- and bispecific human therapeutic antibodies.</li></ul><div class=\"tiny-share-widget\" data-id=\"3324183\" data-linked=\"Ligand Pharma out-licenses OmniAb platform to Ferring Pharma; shares up 3%\" data-tweet=\"$LGND - Ligand Pharma out-licenses OmniAb platform to Ferring Pharma; shares up 3% https://seekingalpha.com/news/3324183-ligand-pharma-out-licenses-omniab-platform-to-ferring-pharma-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3324183-ligand-pharma-out-licenses-omniab-platform-to-ferring-pharma-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324181\" data-ts=\"1516641629\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NYMX\" target=\"_blank\">NYMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324181-nymox-pharmas-fexapotide-shows-long-term-benefit-in-men-low-grade-prostate-cancer-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nymox Pharma&#39;s fexapotide shows long-term benefit in men with low-grade prostate cancer; shares ahead 20%</a></h4><ul><li>Thinly traded micro cap Nymox Pharmaceutical (<a href='https://seekingalpha.com/symbol/NYMX' title='Nymox Pharmaceutical Corporation'>NYMX</a> <font color='green'>+19.8%</font>) is up on a healthy 28x surge in volume on the heels of its <a href=\"https://seekingalpha.com/pr/17052479-nymox-reports-5-year-results-prospective-randomized-controlled-prostate-cancer-study\" target=\"_blank\">announcement </a>of positive long-term data on lead drug fexapotide in men with low-grade localized prostate cancer.</li><li>Topline five-year results showed that a single 15 mg dose resulted in 80% less surgery or radiotherapy associated with cancer progression compared to control. 4.4% of fexapotide-treated patients experienced cancer progression, measured by a scale called Gleason primary pattern grade, compared to 23.5% for control (p=0.0061).</li><li><a href=\"http://www.nymox.com/default.action?itemid=23\" target=\"_blank\">Fexapotide&nbsp;triflutate</a> (NX-1207)&nbsp;is a pro-apoptotic (promotes cell death) protein administered directly into the prostate via a transrectal injection that does not require anesthesia or sedation.</li><li>The company's marketing application in Europe seeking approval to use fexapotide to treat men with enlarged prostates is currently under EMA review.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3295520-nymoxs-marketing-application-europe-bph-med-fexapotide-triflutate-accepted-review-shares\" target=\"_blank\">Nymox's marketing application in Europe for BPH med fexapotide triflutate accepted for review; shares ahead 8%</a> (Sept. 14, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3324181\" data-linked=\"Nymox Pharma&#39;s fexapotide shows long-term benefit in men with low-grade prostate cancer; shares ahead 20%\" data-tweet=\"$NYMX - Nymox Pharma&#39;s fexapotide shows long-term benefit in men with low-grade prostate cancer; shares ahead 20% https://seekingalpha.com/news/3324181-nymox-pharmas-fexapotide-shows-long-term-benefit-in-men-low-grade-prostate-cancer-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3324181-nymox-pharmas-fexapotide-shows-long-term-benefit-in-men-low-grade-prostate-cancer-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324180\" data-ts=\"1516641048\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SANM\" target=\"_blank\">SANM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324180-b-riley-outlines-sanmina-supply-chain-after-negative-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">B. Riley outlines Sanmina supply chain after negative guidance</a></h4><ul><li>        B. Riley looks at the <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20180122112945SANM\" target=\"_blank\">supply chain</a> after Sanmina&rsquo;s (<a href='https://seekingalpha.com/symbol/SANM' title='Sanmina Corp'>SANM</a> <font color='red'>-24%</font>) negative Q1 guidance.</li><li>               Ciena (<a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a> <font color='red'>-0.5%</font>) (Buy rating, $27.50 price target) and Nokia (<a href='https://seekingalpha.com/symbol/NOK' title='Nokia Corporation'>NOK</a> <font color='green'>+0.3%</font>) are both customers of Sanmina and they represent large customers for Lumentum (<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a> <font color='red'>-7.6%</font>) (Buy rating, $89 price target), Oclaro (<a href='https://seekingalpha.com/symbol/OCLR' title='Oclaro, Inc.'>OCLR</a> <font color='red'>-1%</font>) (Buy rating, $9 price target), and Neophotonics (<a href='https://seekingalpha.com/symbol/NPTN' title='NeoPhotonics Corporation'>NPTN</a> <font color='green'>+4.2%</font>) (Neutral rating, $5 price target.)&nbsp;</li><li>                  Firm thinks the order push-outs within Sanmina&rsquo;s Communications segment provide added evidence that CY18 Q1 will have weakness with demand starting to pick up in 2H18.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3323997-sanmina-sinks-earnings-revenue-warning\" target=\"_blank\">Sanmina sinks on earnings, revenue warning</a> (Jan. 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3324180\" data-linked=\"B. Riley outlines Sanmina supply chain after negative guidance\" data-tweet=\"$SANM $SANM $CIEN - B. Riley outlines Sanmina supply chain after negative guidance https://seekingalpha.com/news/3324180-b-riley-outlines-sanmina-supply-chain-after-negative-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3324180-b-riley-outlines-sanmina-supply-chain-after-negative-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324178\" data-ts=\"1516640603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324178-consumer-top-gainers-losers-of-12-00-pm-1-22-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm (1/22/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KODK' title='Eastman Kodak Co.'>KODK</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/VUZI' title='Vuzix Corp'>VUZI</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FORD' title='Forward Industries, Inc.'>FORD</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/OTIV' title='On Track Innovations Ltd'>OTIV</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/FUV' title='Arcimoto, Inc.'>FUV</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3324178\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm (1/22/2018)\" data-tweet=\"$KODK $VUZI $FORD - Consumer - Top Gainers / Losers as of 12:00 pm (1/22/2018) https://seekingalpha.com/news/3324178-consumer-top-gainers-losers-of-12-00-pm-1-22-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3324178-consumer-top-gainers-losers-of-12-00-pm-1-22-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324170\" data-ts=\"1516639175\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RELX\" target=\"_blank\">RELX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324170-relxminus-2_5-morgan-stanley-rates-fully-valued\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RELX -2.5% as Morgan Stanley rates it fully valued</a></h4><ul>   <li>Publisher RELX (NYSE:<a href='https://seekingalpha.com/symbol/RELX' title='RELX PLC'>RELX</a>) is <font color='red'>off 2.5%</font> in U.S. trading as Morgan Stanley moves to Equal Weight from Overweight, pointing to a fully valued (if still high-quality) company.</li>    <li>The former Reed Elsevier is seeing greater risk than usual to its typical \"4-6-8\" growth formula of organic revenue, EBITA and EPS growth, MS says, due to revenue slowdowns in the areas of Scientific, Technical and Media and Risk.</li>    <li>It's cut its estimate for organic revenue growth to 3.5% for this year from 3.8%, and 3.5% for 2019 from 3.7%. (h/t Bloomberg)</li>    <li>Who does it like better among its peer group now? Wolters Kluwer (<a href='https://seekingalpha.com/symbol/WTKWY' title='Wolters Kluwer N.V. ADR'>OTCPK:WTKWY</a> <font color='red'>-0.5%</font>), which it says has a better mix of growth.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324170\" data-linked=\"RELX -2.5% as Morgan Stanley rates it fully valued\" data-tweet=\"$RELX $RELX $WTKWY - RELX -2.5% as Morgan Stanley rates it fully valued https://seekingalpha.com/news/3324170-relxminus-2_5-morgan-stanley-rates-fully-valued?source=tweet\" data-url=\"https://seekingalpha.com/news/3324170-relxminus-2_5-morgan-stanley-rates-fully-valued\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324169\" data-ts=\"1516639073\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASND\" target=\"_blank\">ASND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324169-fda-ad-coms-to-meet-to-clarify-objective-of-phase-3-program-for-dwarfism\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA Ad Coms to meet to clarify objective of Phase 3 program for dwarfism</a></h4><ul><li>The FDA's Pediatric Advisory Committee and Endocrinologic and Metabolic Drugs Advisory Committee will <a href=\"https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-01120.pdf\" target=\"_blank\">meet </a>on March 22 to discuss the objectives of a Phase 3 program for children with <a href=\"https://ghr.nlm.nih.gov/condition/achondroplasia\" target=\"_blank\">achondroplasia</a>, a form of short-limbed dwarfism.</li><li>Related tickers:&nbsp;Ascendis Pharma A/S (<a href='https://seekingalpha.com/symbol/ASND' title='Ascendis Pharma'>ASND</a> <font color='green'>+3.7%</font>) with lead product candidate <a href=\"http://ascendispharma.com/product-pipeline/transcon-growth-hormone/\" target=\"_blank\">TransCon Growth Hormone</a>. BioMarin Pharmaceutical (<a href='https://seekingalpha.com/symbol/BMRN' title='BioMarin Pharmaceutical Inc.'>BMRN</a> <font color='green'>+1.4%</font>) with achondroplasia candidate <a href=\"http://www.biomarin.com/products/pipeline/bmn-111/\" target=\"_blank\">vosoritide </a>(BMN 111).</li></ul><div class=\"tiny-share-widget\" data-id=\"3324169\" data-linked=\"FDA Ad Coms to meet to clarify objective of Phase 3 program for dwarfism\" data-tweet=\"$ASND $ASND $BMRN - FDA Ad Coms to meet to clarify objective of Phase 3 program for dwarfism https://seekingalpha.com/news/3324169-fda-ad-coms-to-meet-to-clarify-objective-of-phase-3-program-for-dwarfism?source=tweet\" data-url=\"https://seekingalpha.com/news/3324169-fda-ad-coms-to-meet-to-clarify-objective-of-phase-3-program-for-dwarfism\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324165\" data-ts=\"1516638575\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VZ\" target=\"_blank\">VZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324165-verizon-up-scotiabank-joins-bull-camp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Verizon up as Scotiabank joins bull camp</a></h4><ul>   <li>Verizon (NYSE:<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications'>VZ</a>) is <font color='green'>up 1.6%</font> and inching closer to its 52-week high after an upgrade to Sector Outperform by Scotiabank.</li>    <li>The firm's set a price target of $60, up from a previous $50, implying 14% upside from today's pricing.</li>    <li>Scotiabank's departing from mostly Neutral analyst sentiment on the stock; after a roller-coaster year, Verizon's share are essentially flat over the past 12 months, down just a few pennies.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324165\" data-linked=\"Verizon up as Scotiabank joins bull camp\" data-tweet=\"$VZ - Verizon up as Scotiabank joins bull camp https://seekingalpha.com/news/3324165-verizon-up-scotiabank-joins-bull-camp?source=tweet\" data-url=\"https://seekingalpha.com/news/3324165-verizon-up-scotiabank-joins-bull-camp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324164\" data-ts=\"1516638344\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OKTA\" target=\"_blank\">OKTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324164-fbn-initiates-okta-20-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FBN initiates Okta with 20% upside</a></h4><ul><li>        FBN Securities <a href=\"https://www.streetinsider.com/Analyst+Comments/FBN+Securities+Starts+Okta%2C+Inc+%28OKTA%29+at+Outperform/13707048.html\" target=\"_blank\">initiates</a> Okta (NASDAQ:<a href='https://seekingalpha.com/symbol/OKTA' title='Okta, Inc.'>OKTA</a>) with an Outperform rating and a $35 price target (20% upside on Friday&rsquo;s close.)</li><li>               Analyst Shebly Seyrafi calls the company a &ldquo;leading player in the access/identity management space.&rdquo;&nbsp;</li><li>               Okta shares are&nbsp;<font color='green'>up 3.3%</font>&nbsp;to $30.15. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3324164\" data-linked=\"FBN initiates Okta with 20% upside\" data-tweet=\"$OKTA - FBN initiates Okta with 20% upside https://seekingalpha.com/news/3324164-fbn-initiates-okta-20-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3324164-fbn-initiates-okta-20-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324163\" data-ts=\"1516638243\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLKS\" target=\"_blank\">FLKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324163-flex-pharma-hires-advisor-to-assist-strategic-alternatives-for-hotshot-business-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Flex Pharma hires advisor to assist with strategic alternatives for HOTSHOT business; shares up 4%</a></h4><ul><li>In a regulatory filing, Flex Pharma (<a href='https://seekingalpha.com/symbol/FLKS' title='Flex Pharma'>FLKS</a> <font color='green'>+3.6%</font>) <a href=\"https://www.sec.gov/Archives/edgar/data/1615219/000161521918000009/a8-k.htm\" target=\"_blank\">reports </a>that it has hired investment banker Business Capital Exchange to assist with the evaluation of strategic alternatives for its HOTSHOT consumer products business.</li><li><a href=\"http://www.flex-pharma.com/focus.php\" target=\"_blank\">HOTSHOT </a>is a drinkable \"sports shot\" aimed at preventing and treating muscle cramps.</li></ul><div class=\"tiny-share-widget\" data-id=\"3324163\" data-linked=\"Flex Pharma hires advisor to assist with strategic alternatives for HOTSHOT business; shares up 4%\" data-tweet=\"$FLKS $SLRX - Flex Pharma hires advisor to assist with strategic alternatives for HOTSHOT business; shares up 4% https://seekingalpha.com/news/3324163-flex-pharma-hires-advisor-to-assist-strategic-alternatives-for-hotshot-business-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3324163-flex-pharma-hires-advisor-to-assist-strategic-alternatives-for-hotshot-business-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324128\" data-ts=\"1516637941\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324128-healthcare-top-5-gainers-losers-of-11-15-1-22-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:15 am (1/22/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/BIVV' title='Bioverativ Inc.'>BIVV</a> <font color='green'>+62%</font>. <a href='https://seekingalpha.com/symbol/JUNO' title='Juno Therapeutics'>JUNO</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/ZIOP' title='ZIOPHARM Oncology, Inc.'>ZIOP</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a> <font color='green'>+16%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/VICL' title='Vical Incorporated'>VICL</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/IDRA' title='Idera Pharmaceuticals, Inc.'>IDRA</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/TYHT' title='Shineco, Inc.'>TYHT</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics'>ONTX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CTIC' title='CTI BioPharma Corp.'>CTIC</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3324128\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:15 am (1/22/2018)\" data-tweet=\"$BIVV $JUNO $SRNE - Healthcare - Top 5 Gainers / Losers as of 11:15 am (1/22/2018) https://seekingalpha.com/news/3324128-healthcare-top-5-gainers-losers-of-11-15-1-22-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3324128-healthcare-top-5-gainers-losers-of-11-15-1-22-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324158\" data-ts=\"1516637884\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCK\" target=\"_blank\">CCK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324158-upslope-capital-turns-around-on-crown-holdings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Upslope Capital turns around on Crown Holdings</a></h4><ul>     <li>Upslope Capital Management discloses that it exited its long position on Crown Holdings (<a href='https://seekingalpha.com/symbol/CCK' title='Crown Holdings Inc.'>CCK</a> <font color='red'>-0.1%</font>) and went short following the company's $3.9B <a href=\"https://seekingalpha.com/news/3319138-crown-holdings-buy-signode-industrial-carlyle-3_9b\" target=\"_blank\">acquisition</a> of Signode.</li>     <li>Upslope's George Livadas likes the short side odds now due to the \"flimsy\" strategic rationale by Crown for the pricey acquisition.</li>      <li><a href=\"https://seekingalpha.com/article/4138932-upslope-capital-q4-2017-investor-letter?cache=0.06482427197982721\" target=\"_blank\">Full Upslope Capital Q4 letter</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3324158\" data-linked=\"Upslope Capital turns around on Crown Holdings\" data-tweet=\"$CCK - Upslope Capital turns around on Crown Holdings https://seekingalpha.com/news/3324158-upslope-capital-turns-around-on-crown-holdings?source=tweet\" data-url=\"https://seekingalpha.com/news/3324158-upslope-capital-turns-around-on-crown-holdings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324154\" data-ts=\"1516637543\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNIT-OLD\" target=\"_blank\">CNIT-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324154-cnitplus-6_8-on-blockchain-research-plans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CNIT +6.8% on blockchain research plans</a></h4><ul><li>        China Information Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/CNIT-OLD' title='China Information Technology'>CNIT-OLD</a>) shares trade&nbsp;<font color='green'>up 6.8%</font>&nbsp;on news the company has <a href=\"https://seekingalpha.com/pr/17052040-cnit-announces-research-applying-blockchain-technology-innovate-taoping-new-media-ecosystem\" target=\"_blank\">launched research</a> into blockchain application. &nbsp;</li><li>        The aim is to &ldquo;find a more efficient and secure solution for payment transfer, and a better mechanism to collect internal data and reward end users.&rdquo;</li><li>               CNIT expects to upgrade the accuracy of ad distribution on terminals and improve the consumer experience.&nbsp;</li><li>                  Taoping Net and Taoping APP are currently used to buy and distribute real-time ads to more than 10K terminals in 10 cities in China.    &nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3324154\" data-linked=\"CNIT +6.8% on blockchain research plans\" data-tweet=\"$CNIT-OLD - CNIT +6.8% on blockchain research plans https://seekingalpha.com/news/3324154-cnitplus-6_8-on-blockchain-research-plans?source=tweet\" data-url=\"https://seekingalpha.com/news/3324154-cnitplus-6_8-on-blockchain-research-plans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324150\" data-ts=\"1516636862\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZIOP\" target=\"_blank\">ZIOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324150-ziopharm-riding-celgene-juno-wave-up-22\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ZIOPHARM riding the Celgene/Juno wave, up 22%</a></h4><ul><li>Buying has spiked in ZIOPHARM Oncology (<a href='https://seekingalpha.com/symbol/ZIOP' title='ZIOPHARM Oncology, Inc.'>ZIOP</a> <font color='green'>+22%</font>) on the heels of Celgene's (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='green'>+0.1%</font>) takeout of Juno Therapeutics (<a href='https://seekingalpha.com/symbol/JUNO' title='Juno Therapeutics'>JUNO</a> <font color='green'>+26.9%</font>). Shares are up on 33% higher volume.</li><li>The company is developing CAR-T therapies with Intrexon (<a href='https://seekingalpha.com/symbol/XON' title='Intrexon Corp'>XON</a> <font color='green'>+11.4%</font>).</li><li>Related tickers: (<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a> <font color='green'>+10%</font>)(<a href='https://seekingalpha.com/symbol/CLLS' title='Cellectis S.A.'>CLLS</a> <font color='green'>+9.8%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3324150\" data-linked=\"ZIOPHARM riding the Celgene/Juno wave, up 22%\" data-tweet=\"$ZIOP $ZIOP $CELG - ZIOPHARM riding the Celgene/Juno wave, up 22% https://seekingalpha.com/news/3324150-ziopharm-riding-celgene-juno-wave-up-22?source=tweet\" data-url=\"https://seekingalpha.com/news/3324150-ziopharm-riding-celgene-juno-wave-up-22\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324149\" data-ts=\"1516636766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324149-jana-reveals-stake-in-teva-pharma\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jana reveals stake in Teva Pharma</a></h4><ul><li>A believer in Teva Pharmaceutical's (NYSE:<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a>) turnaround plan, Jana Partners has built a stake in the company, believing the stock to be worth $30 (<font color='green'>50% upside</font>), according to an investor letter.</li><li>Down earlier following<a href=\"https://seekingalpha.com/news/3324092-tevas-subcutaneously-administered-reslizumab-flunks-late-stage-asthma-study-shares-3-percent\" target=\"_blank\"> a trial failure</a>, Teva is&nbsp;<font color='green'>ahead 1%&nbsp;</font>in mid-morning action.</li></ul><div class=\"tiny-share-widget\" data-id=\"3324149\" data-linked=\"Jana reveals stake in Teva Pharma\" data-tweet=\"$TEVA - Jana reveals stake in Teva Pharma https://seekingalpha.com/news/3324149-jana-reveals-stake-in-teva-pharma?source=tweet\" data-url=\"https://seekingalpha.com/news/3324149-jana-reveals-stake-in-teva-pharma\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324146\" data-ts=\"1516636251\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCS\" target=\"_blank\">BCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324146-barclays-up-nearly-5-on-tiger-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barclays up nearly 5% on Tiger stake</a></h4><ul><li>Tiger Global is apparently a believer Jes Staley's turnaround plans for Barclays (<a href='https://seekingalpha.com/symbol/BCS' title='Barclays PLC'>BCS</a> <font color='green'>+4.4%</font>), as <a href=\"https://www.ft.com/content/e768ce1e-fd54-11e7-9b32-d7d59aace167\" target=\"_blank\">the <em>FT</em> reports</a> the hedge fund as having quietly amassed more than a $1B stake in the bank, making it a top-10 holder. According to a source, Tiger was a buyer of a 2.5% stake in Barclays near the lows last November.</li></ul><div class=\"tiny-share-widget\" data-id=\"3324146\" data-linked=\"Barclays up nearly 5% on Tiger stake\" data-tweet=\"$BCS - Barclays up nearly 5% on Tiger stake https://seekingalpha.com/news/3324146-barclays-up-nearly-5-on-tiger-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3324146-barclays-up-nearly-5-on-tiger-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324145\" data-ts=\"1516636084\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRNE\" target=\"_blank\">SRNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324145-sorrento-builds-on-up-move-shares-ahead-19\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sorrento builds on up move, shares ahead 19%</a></h4><ul><li>Sorrento Therapeutics (<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a> <font color='green'>+18.7%</font>) continues its upward march on more than double normal volume. Shares have tripled since early December.</li><li>In an <a href=\"https://seekingalpha.com/filing/3838778\" target=\"_blank\">SEC filing</a> today, the company reported that it acquired 1,801,801 shares of common stock and warrants to purchase up to 261,438 shares from a third party for a total of $11,531,526.40 ($6.40/share).</li><li>Last month, it filed a <a href=\"https://www.sec.gov/Archives/edgar/data/850261/000114420417062650/tv480888_424b5.htm\" target=\"_blank\">prospectus </a>for a $100M stock offering.</li><li>February 28 is the FDA's action date for its resubmitted marketing application for ZTlido (lidocaine patch 1.8%) for the treatment of postherpetic neuralgia (shingles).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3294799-fda-accepts-sorrentos-resubmitted-marketing-application-ztlido-action-date-february-28-2018\" target=\"_blank\">FDA accepts Sorrento's resubmitted marketing application for ZTlido, action date February 28, 2018</a> (Sept. 12, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3324145\" data-linked=\"Sorrento builds on up move, shares ahead 19%\" data-tweet=\"$SRNE - Sorrento builds on up move, shares ahead 19% https://seekingalpha.com/news/3324145-sorrento-builds-on-up-move-shares-ahead-19?source=tweet\" data-url=\"https://seekingalpha.com/news/3324145-sorrento-builds-on-up-move-shares-ahead-19\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324144\" data-ts=\"1516635913\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTC\" target=\"_blank\">PTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324144-ptcplus-1_9-after-reports-of-new-jana-stake-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PTC +1.9% after reports of a new Jana stake (update)</a></h4><ul><li>PTC (NASDAQ:<a href='https://seekingalpha.com/symbol/PTC' title='PTC Inc.'>PTC</a>) shares trading&nbsp;<font color='green'>up 1.9%</font>&nbsp;after <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20180122101125PTC\" target=\"_blank\">reports</a> that Jana has taken a new stake in the company.</li><li>Will update with more details if/when available.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3324141-autodesk-plus-2_1-percent-rumors-jana-stake\" target=\"_blank\">Autodesk +2.1% on rumors of a Jana stake</a> (Jan. 22)</li><li>Update: Jana calls PTC the Autodesk of industrial applications and sees an undiscounted target price of over $100 per share, which represents a 40% upside on Friday's closing price at the low end.</li><li>Jana sees PTC as an attractive takeover candidate.</li><li>Source: Bloomberg First Word</li></ul><div class=\"tiny-share-widget\" data-id=\"3324144\" data-linked=\"PTC +1.9% after reports of a new Jana stake (update)\" data-tweet=\"$PTC - PTC +1.9% after reports of a new Jana stake (update) https://seekingalpha.com/news/3324144-ptcplus-1_9-after-reports-of-new-jana-stake-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3324144-ptcplus-1_9-after-reports-of-new-jana-stake-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324141\" data-ts=\"1516635291\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADSK\" target=\"_blank\">ADSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324141-autodeskplus-2_1-on-rumors-of-jana-stake-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Autodesk +2.1% on rumors of a Jana stake (update)</a></h4><ul><li>Autodesk (NASDAQ:<a href='https://seekingalpha.com/symbol/ADSK' title='Autodesk, Inc.'>ADSK</a>) shares&nbsp;<font color='green'>up 2.1%</font>&nbsp;on <a href=\"https://twitter.com/WizAtWallSt/status/955456591544946688\" target=\"_blank\">rumors</a> that Jana has taken a stake in the company.</li><li>Jana <a href=\"https://twitter.com/cfromhertz/status/955456678241153024\" target=\"_blank\">reportedly</a> has a $160 price target on Autodesk, which represents a 39% upside on Friday&rsquo;s closing price.</li><li>Update: Stake and price target confirmed by Bloomberg First Word.</li></ul><div class=\"tiny-share-widget\" data-id=\"3324141\" data-linked=\"Autodesk +2.1% on rumors of a Jana stake (update)\" data-tweet=\"$ADSK - Autodesk +2.1% on rumors of a Jana stake (update) https://seekingalpha.com/news/3324141-autodeskplus-2_1-on-rumors-of-jana-stake-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3324141-autodeskplus-2_1-on-rumors-of-jana-stake-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324139\" data-ts=\"1516634857\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BP\" target=\"_blank\">BP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324139-bloomberg-bp-weighs-bid-for-1_8b-italian-solar-firm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: BP weighs bid for $1.8B Italian solar firm</a></h4><ul>     <li>BP (<a href='https://seekingalpha.com/symbol/BP' title='BP p.l.c.'>BP</a> <font color='green'>+1.7%</font>) is <a href=\"https://www.bloomberg.com/news/articles/2018-01-22/bp-is-said-to-weigh-bid-for-1-8-billion-italian-solar-company\" target=\"_blank\">considering a bid</a> for one of Italy&rsquo;s largest collection of solar assets valued at ~&euro;1.5B ($1.8B), Bloomberg reports.</li>     <li>P-E firm Terra Firma Capital Partners will kick off the sale of Rete Rinnovabile next month, which also is attracting interest from companies from China to Abu Dhabi, as well as German utility E.ON (<a href='https://seekingalpha.com/symbol/EONGY' title='E.ON SE ADR'>OTCPK:EONGY</a>), according to the report.</li>     <li>BP returned to the solar power market <a href=\"https://seekingalpha.com/news/3318563-bp-returns-solar-200m-stake-lightsource\" target=\"_blank\">last month</a> with a $200M investment in Lightsource Renewable Energy, and Royal Dutch Shell also has been <a href=\"https://seekingalpha.com/news/3323774-shell-signs-five-year-supply-deal-u-k-s-second-largest-solar-plant\" target=\"_blank\">expanding its interests in renewables</a> as companies increasingly seek cleaner forms of energy.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324139\" data-linked=\"Bloomberg: BP weighs bid for $1.8B Italian solar firm\" data-tweet=\"$BP $BP $EONGY - Bloomberg: BP weighs bid for $1.8B Italian solar firm https://seekingalpha.com/news/3324139-bloomberg-bp-weighs-bid-for-1_8b-italian-solar-firm?source=tweet\" data-url=\"https://seekingalpha.com/news/3324139-bloomberg-bp-weighs-bid-for-1_8b-italian-solar-firm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324137\" data-ts=\"1516634325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANTH\" target=\"_blank\">ANTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324137-anthera-on-go-to-report-results-from-late-stage-study-of-sollpura-in-epi-this-quarter-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anthera on go to report results from late-stage study of Sollpura in EPI this quarter; shares ahead 3%</a></h4><ul><li>Anthera Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ANTH' title='Anthera Pharmaceuticals, Inc.'>OTC:ANTH</a> <font color='green'>+3.1%</font>) is up on 40% higher volume in response to its <a href=\"https://seekingalpha.com/pr/17052138-anthera-announces-positive-outcome-second-interim-futility-analysis-phase-3-result-clinical\" target=\"_blank\">announcement </a>that the second pre-planned futility analysis has been completed on the Phase 3 RESULT study assessing Sollpura for the treatment of exocrine pancreatic insufficiency &#40;EPI&#41;.</li><li>The independent Data Monitoring Committee gave its thumbs up, clearing the way for reporting topline results later this quarter.</li><li>The company says Sollpura has the potential to become the first non-porcine pancreatic enzyme replacement therapy which may enable a reduction in pill size and number for EPI patients.</li></ul><div class=\"tiny-share-widget\" data-id=\"3324137\" data-linked=\"Anthera on go to report results from late-stage study of Sollpura in EPI this quarter; shares ahead 3%\" data-tweet=\"$ANTH - Anthera on go to report results from late-stage study of Sollpura in EPI this quarter; shares ahead 3% https://seekingalpha.com/news/3324137-anthera-on-go-to-report-results-from-late-stage-study-of-sollpura-in-epi-this-quarter-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3324137-anthera-on-go-to-report-results-from-late-stage-study-of-sollpura-in-epi-this-quarter-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324136\" data-ts=\"1516634078\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BG\" target=\"_blank\">BG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324136-bunge-be-valued-much-100-share-in-potential-adm-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bunge could be valued at as much as $100/share in potential ADM deal</a></h4><ul>     <li>Bunge (<a href='https://seekingalpha.com/symbol/BG' title='Bunge Limited'>BG</a> <font color='green'>+2.7%</font>) adds to Friday's last-minute surge that followed a report that Archer Daniels Midland (<a href='https://seekingalpha.com/symbol/ADM' title='Archer Daniels Midland Co.'>ADM</a> <font color='green'>+1.9%</font>) <a href=\"https://seekingalpha.com/news/3323979-wsj-adm-makes-takeover-approach-bunge\" target=\"_blank\">sought merger talks</a> with the company, potentially setting up a bidding war with Glencore (<a href='https://seekingalpha.com/symbol/GLCNF' title='Glencore Plc'>OTCPK:GLCNF</a>, <a href='https://seekingalpha.com/symbol/GLNCY' title='Glencore Plc ADR'>OTCPK:GLNCY</a>).</li>     <li>Stephens analyst Farha Aslam was surprised by news of the potential deal, since BG&rsquo;s product portfolio is far more commodity-oriented vs. the value-added strategy that ADM has been articulating, but a deal could create significant synergies.</li><li>Credit Suisse's Robert Moskow thinks a deal would make sense strategically for ADM, as  it would create significant scale in South American, European and Asian  markets, and eliminate excess capacity in regions where margins have come  down; he suspects ADM may be trying to get BG at the negotiating table before the standstill agreement with Glencore expires in February.</li><li>Citi's David Driscoll believes BG would be valued at $85-$100/share, but a deal would be less attractive if ADM is unable to hold onto BG&rsquo;s North American and European crushing  assets in a deal due to regulatory challenges.</li><li>Source:&nbsp;Bloomberg First Word</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324136\" data-linked=\"Bunge could be valued at as much as $100/share in potential ADM deal\" data-tweet=\"$BG $BG $ADM - Bunge could be valued at as much as $100/share in potential ADM deal https://seekingalpha.com/news/3324136-bunge-be-valued-much-100-share-in-potential-adm-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3324136-bunge-be-valued-much-100-share-in-potential-adm-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324135\" data-ts=\"1516633495\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANF\" target=\"_blank\">ANF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324135-abercrombie-fitch-rallies-after-guidance-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abercrombie &amp; Fitch rallies after guidance update</a></h4><ul> <li>Abercrombie &amp; Fitch (<a href='https://seekingalpha.com/symbol/ANF' title='Abercrombie & Fitch'>ANF</a> <font color='green'>+8.5%</font>) updates on Q4 results.</li> <li>The retailer expects to report comparable sales to be up at a high-single digit rate vs. prior outlook for a low-single digit gain.</li> <li>Total sales are seen to be up at a low-teens rate.</li> <li>A&amp;F anticipates gross profit to be in-line with its prior outlook for ~58.3% of sales.</li> <li>CEO update: \"We are pleased by our performance across all brands and channels during the holiday season, with continued strength at Hollister, and the Abercrombie brand on track to deliver positive comparable sales for the quarter. Our customers remain at the center of all we do, and that singular focus has continued to drive both our brands forward.\"</li> <li>The company is due to report full results on March 7.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324135\" data-linked=\"Abercrombie &amp; Fitch rallies after guidance update\" data-tweet=\"$ANF - Abercrombie &amp; Fitch rallies after guidance update https://seekingalpha.com/news/3324135-abercrombie-fitch-rallies-after-guidance-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3324135-abercrombie-fitch-rallies-after-guidance-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324133\" data-ts=\"1516633151\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IIVI\" target=\"_blank\">IIVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324133-ii-viminus-3_6-on-analyst-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">II-VI -3.6% on analyst downgrade</a></h4><ul><li>        Northland Capital Markets downgrades II-VI (NASDAQ:<a href='https://seekingalpha.com/symbol/IIVI' title='II-VI Incorporated'>IIVI</a>) from Outperform to Market Perform with a $51 price target, which is 4% below Friday&rsquo;s closing price.</li><li>               Latest analyst <a href=\"https://markets.ft.com/data/equities/tearsheet/forecasts?s=IIVI:NSQ\" target=\"_blank\">recommendations</a>: 2 Buy, 2 Outperform, and 1 Hold.&nbsp;</li><li>               Median price target: $52.&nbsp;</li><li>               II-VI shares are&nbsp;<font color='red'>down 3.6%</font>&nbsp;to $51.03.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3324133\" data-linked=\"II-VI -3.6% on analyst downgrade\" data-tweet=\"$IIVI - II-VI -3.6% on analyst downgrade https://seekingalpha.com/news/3324133-ii-viminus-3_6-on-analyst-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3324133-ii-viminus-3_6-on-analyst-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324131\" data-ts=\"1516632849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XRX\" target=\"_blank\">XRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324131-xerox-under-tag-team-pressure-from-influential-shareholders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xerox under tag team pressure from influential shareholders</a></h4><ul> <li>Shares of Xerox (NYSE:<a href='https://seekingalpha.com/symbol/XRX' title='Xerox Corporation'>XRX</a>) are <font color='green'>up 1.55</font>% as the alliance between Carl Icahn and Darwin Deason strengthens.</li> <li>The influential investors issued a joint statement earlier today in which they said they are completely aligned in pushing for board changes at Xerox and a renegotiation or termination of the Fuji Xerox JV.</li> <li>Icahn and Deason: \"We have little faith that Xerox's 'old guard' directors will listen to us, which is why real change is needed now more than ever. Every day that the 'old guard' remains in power -- feebly overseeing the company's steady decline -- is a waste of time that could inevitably erode the value of our investment down to nothing.\"</li> <li><a href=\"https://seekingalpha.com/pr/17052290-carl-icahn-darwin-deason-release-joint-statement-regarding-xerox-corporation\" target=\"_blank\">Full joint statement</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3324131\" data-linked=\"Xerox under tag team pressure from influential shareholders\" data-tweet=\"$XRX - Xerox under tag team pressure from influential shareholders https://seekingalpha.com/news/3324131-xerox-under-tag-team-pressure-from-influential-shareholders?source=tweet\" data-url=\"https://seekingalpha.com/news/3324131-xerox-under-tag-team-pressure-from-influential-shareholders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324127\" data-ts=\"1516632325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACIA\" target=\"_blank\">ACIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324127-commonwealth-capital-ventures-lowers-acacia-communications-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Commonwealth Capital Ventures lowers its Acacia Communications stake</a></h4><ul><li>        Commonwealth Capital Ventures <a href=\"https://seekingalpha.com/filing/3838894\" target=\"_blank\">lowers</a> its passive stake in Acacia Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/ACIA' title='Acacia Communications'>ACIA</a>) to 4.4% <a href=\"https://www.sec.gov/Archives/edgar/data/1385031/000119312517000550/d325380dsc13g.htm\" target=\"_blank\">from</a> 14.3%.</li><li>               Acacia shares are&nbsp;<font color='red'>down 0.6%</font>.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3324127\" data-linked=\"Commonwealth Capital Ventures lowers its Acacia Communications stake\" data-tweet=\"$ACIA - Commonwealth Capital Ventures lowers its Acacia Communications stake https://seekingalpha.com/news/3324127-commonwealth-capital-ventures-lowers-acacia-communications-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3324127-commonwealth-capital-ventures-lowers-acacia-communications-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324120\" data-ts=\"1516631350\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FE\" target=\"_blank\">FE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324120-firstenergyplus-9-after-transformational-2_5b-equity-investment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FirstEnergy +9% after &#39;transformational&#39; $2.5B equity investment</a></h4><ul>     <li>FirstEnergy (NYSE:<a href='https://seekingalpha.com/symbol/FE' title='FirstEnergy Corp'>FE</a>) <font color='green'>+8.9%</font> premarket after announcing a \"transformational\" <a href=\"https://seekingalpha.com/pr/17052291-firstenergy-announces-transformational-2_5-billion-equity-investment\" target=\"_blank\">$2.5B investment in the company</a> from affiliates of Elliott Management, Bluescape, GIC and Zimmer Partners.</li>     <li>The investment includes $1.62B in mandatory  convertible preferred equity and $850M of common equity which FE says will be used to reduce its debt, contribute to its pension fund and strengthen its balance sheet.</li>     <li>FE previously disclosed that it expected to issue at least $1.5B of common equity through 2019, but this investment will satisfy that need, and the company says it should not need to issue additional equity through the end of 2020.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324120\" data-linked=\"FirstEnergy +9% after &#39;transformational&#39; $2.5B equity investment\" data-tweet=\"$FE - FirstEnergy +9% after &#39;transformational&#39; $2.5B equity investment https://seekingalpha.com/news/3324120-firstenergyplus-9-after-transformational-2_5b-equity-investment?source=tweet\" data-url=\"https://seekingalpha.com/news/3324120-firstenergyplus-9-after-transformational-2_5b-equity-investment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324119\" data-ts=\"1516631302\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNN\" target=\"_blank\">WYNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324119-wynn-resorts-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wynn Resorts beats by $0.02, beats on revenue</a></h4><ul><li>Wynn Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>): Q4 EPS of $1.40 <font color='green'>beats by $0.02</font>.</li><li>Revenue of $1.69B (+30.0% Y/Y) <font color='green'>beats by $120M</font>.</li><li>Shares <font color='green'>+4.04%</font> PM.</li><li><a href='https://seekingalpha.com/pr/17052280-wynn-resorts-limited-reports-fourth-quarter-year-end-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3324119\" data-linked=\"Wynn Resorts beats by $0.02, beats on revenue\" data-tweet=\"$WYNN - Wynn Resorts beats by $0.02, beats on revenue https://seekingalpha.com/news/3324119-wynn-resorts-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3324119-wynn-resorts-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324117\" data-ts=\"1516631068\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324117-premarket-gainers-of-9-05-1-22-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (1/22/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/BIVV' title='Bioverativ Inc.'>BIVV</a>&nbsp;<font color='green'>+63%</font>&nbsp;on being <a href=\"https://seekingalpha.com/news/3324021-sanofi-nears-11_6b-deal-bioverativ\" target=\"_blank\">acquired</a> vy Sanofi (NASDAQ:<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a>).</li>     <li><a href='https://seekingalpha.com/symbol/VR' title='Validus Holdings, Ltd.'>VR</a> <font color='green'>+45%</font>&nbsp;on being <a href=\"https://seekingalpha.com/news/3324057-aig-5_5b-deal-validus-holdings\" target=\"_blank\">acquired</a> by AIG (NYSE:<a href='https://seekingalpha.com/symbol/AIG' title='American International Group Inc'>AIG</a>).</li>     <li><a href='https://seekingalpha.com/symbol/LTBR' title='Lightbridge Corp'>LTBR</a> <font color='green'>+42%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17051946-lightbridge-receives-u-s-approval-key-patent-innovative-fuel-design\" target=\"_blank\">receiving</a> a notice of allowance for a key patent from the U.S. Patent and Trademark Office related to its metallic nuclear fuel assembly design.</li>     <li><a href='https://seekingalpha.com/symbol/TTNP' title='Titan Pharmaceuticals, Inc.'>TTNP</a>&nbsp;<font color='green'>+29%</font>&nbsp;as Braeburn Pharmaceuticals are in <a href=\"https://seekingalpha.com/pr/17051889-titan-discussions-braeburn-regarding-u-s-probuphine-commercialization\" target=\"_blank\">discussions</a> regarding their partnership for the development and commercialization of Probuphine.</li>     <li><a href='https://seekingalpha.com/symbol/JUNO' title='Juno Therapeutics'>JUNO</a> <font color='green'>+27%</font>&nbsp;on being <a href=\"https://seekingalpha.com/news/3324045-celgene-takes-juno-9b\" target=\"_blank\">acquired</a> by Celgene (NASDAQ:<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a>).</li>     <li><a href='https://seekingalpha.com/symbol/CNIT-OLD' title='China Information Technology'>CNIT-OLD</a> <font color='green'>+18%</font>&nbsp;as it has initiated in-depth <a href=\"https://seekingalpha.com/pr/17052040-cnit-announces-research-applying-blockchain-technology-innovate-taoping-new-media-ecosystem\" target=\"_blank\">research</a> on the application of blockchain.</li>     <li><a href='https://seekingalpha.com/symbol/ANTH' title='Anthera Pharmaceuticals, Inc.'>OTC:ANTH</a> <font color='green'>+13%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17052138-anthera-announces-positive-outcome-second-interim-futility-analysis-phase-3-result-clinical\" target=\"_blank\">positive outcome</a> of the second, pre-specified interim futility analysis for the RESULT Phase 3 clinical study of Sollpura for the treatment of Exocrine Pancreatic Insufficiency.</li>     <li><a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a> <font color='green'>+11%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17052170-ocean-power-technologies-signs-agreement-premier-oil\" target=\"_blank\">agreement</a> with Premier Oil (<a href='https://seekingalpha.com/symbol/PMOIY' title='Premier Oil plc ADR'>OTCPK:PMOIY</a>).</li>     <li><a href='https://seekingalpha.com/symbol/NUAN' title='Nuance Communications, Inc.'>NUAN</a> <font color='green'>+11%</font>&nbsp;on prelim <a href=\"https://seekingalpha.com/news/3324089-nuance-plus-8-percent-prelim-q1-results-beat-prior-guidance-consensus\" target=\"_blank\">results</a>.</li>     <li><a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a> <font color='green'>+10%</font>&nbsp;as&nbsp;&nbsp;CRC triplet therapy continues to <a href=\"https://seekingalpha.com/news/3324096-arrays-crc-triplet-therapy-continues-show-positive-effect-late-stage-study-shares-ahead-12\" target=\"_blank\">show</a> positive effect in late-stage study.</li>     <li><a href='https://seekingalpha.com/symbol/RUBI' title='The Rubicon Project, Inc.'>RUBI</a> <font color='green'>+10%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='green'>+9%</font>&nbsp;as crypto <a href=\"https://seekingalpha.com/news/3324112-crypto-selloff-resumes-nordea-bank-bans-taleb-fan\" target=\"_blank\">selloff</a> resumes, Nordea Bank bans.</li>     <li><a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a> <font color='green'>+8%</font>. on Q3&nbsp;<a href=\"https://seekingalpha.com/news/3324076-petmed-express-beats-0_12-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a> <font color='green'>+7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/IOVA' title='Iovance Biotherapeutics, Inc.'>IOVA</a> <font color='green'>+8%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc'>OTC:IGC</a> <font color='green'>+7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a> <font color='green'>+5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324117\" data-linked=\"Premarket Gainers as of 9:05 am (1/22/2018)\" data-tweet=\"$BIVV $SNY $VR - Premarket Gainers as of 9:05 am (1/22/2018) https://seekingalpha.com/news/3324117-premarket-gainers-of-9-05-1-22-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3324117-premarket-gainers-of-9-05-1-22-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324116\" data-ts=\"1516630941\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324116-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Sarepta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a>) initiated with Outperform rating by RBC Capital Markets.</li><li>Dynavax Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/DVAX' title='Dynavax Technologies Corporation'>DVAX</a>) initiated with Outperform rating and $27 (73% upside) price target by RBC.</li><li>Array Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a>) upgraded to Outperform by Leerink.</li><li>Iovance Biotherapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/IOVA' title='Iovance Biotherapeutics, Inc.'>IOVA</a>) a Top Pick for 2018 at Chardan.</li><li>The Medicines Company (NASDAQ:<a href='https://seekingalpha.com/symbol/MDCO' title='The Medicines Company'>MDCO</a>) upgraded to Buy with a $40 (60% upside) price target by Citigroup.</li><li>Ultragenyx Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/RARE' title='Ultragenyx Pharmaceutical Inc.'>RARE</a>) upgraded to Outperform by Evercore ISI.</li><li>Aetna (NYSE:<a href='https://seekingalpha.com/symbol/AET' title='Aetna, Inc.'>AET</a>) upgraded to Buy by Deutsche Bank. Downgraded to Neutral by BTIG Research.</li><li>Charles River Labs (NYSE:<a href='https://seekingalpha.com/symbol/CRL' title='Charles River Laboratories International, Inc.'>CRL</a>) downgraded to Hold by SunTrust.</li><li>Eli Lilly (NYSE:<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a>) downgraded to Neutral by Credit Suisse.</li><li>Abbott (NYSE:<a href='https://seekingalpha.com/symbol/ABT' title='Abbott Laboratories'>ABT</a>) downgraded to Neutral by BTIG.</li><li>Esperion Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ESPR' title='Esperion Therapeutics'>ESPR</a>) downgraded to Neutral by Citigroup.</li></ul><div class=\"tiny-share-widget\" data-id=\"3324116\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$SRPT $SRPT $DVAX - Premarket analyst action - healthcare https://seekingalpha.com/news/3324116-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3324116-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324115\" data-ts=\"1516630843\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIFY\" target=\"_blank\">SIFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324115-sify-technologies-reports-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sify Technologies reports Q3 results</a></h4><ul><li>Sify Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SIFY' title='Sify Technologies Limited'>SIFY</a>): Q3 net profit of&nbsp;\u20b9285M.</li><li>Revenue of&nbsp;\u20b95.23B (+12.7% Y/Y)</li><li>Shares <font color='green'>+9.8%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17052281-sify-reports-revenues-inr-5228-million-third-quarter-fy-2017minus-18\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3324115\" data-linked=\"Sify Technologies reports Q3 results\" data-tweet=\"$SIFY - Sify Technologies reports Q3 results https://seekingalpha.com/news/3324115-sify-technologies-reports-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3324115-sify-technologies-reports-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324113\" data-ts=\"1516630764\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RUBI\" target=\"_blank\">RUBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324113-rubicon-projectplus-11_9-craig-hallum-seeing-double-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rubicon Project +11.9% with Craig-Hallum seeing double upside</a></h4><ul>   <li>The Rubicon Project (NYSE:<a href='https://seekingalpha.com/symbol/RUBI' title='The Rubicon Project, Inc.'>RUBI</a>) is <font color='green'>up 11.9%</font> premarket after a Craig-Hallum upgrade to Buy that points to changing ad-tech trends.</li>    <li>Tailwinds from those trends along with some \"modest\" cost reductions should bring continued improvement in EBITDA and boost the shares, says analyst Jason Kreyer, who has a price target of $4 (99% upside from $2.01).</li>    <li>Shares have <font color='red'>lost 76.4%</font> of value over the past 12 months -- and <font color='red'>declined 41.9%</font> over the past three months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324113\" data-linked=\"Rubicon Project +11.9% with Craig-Hallum seeing double upside\" data-tweet=\"$RUBI - Rubicon Project +11.9% with Craig-Hallum seeing double upside https://seekingalpha.com/news/3324113-rubicon-projectplus-11_9-craig-hallum-seeing-double-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3324113-rubicon-projectplus-11_9-craig-hallum-seeing-double-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324112\" data-ts=\"1516630701\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBTC\" target=\"_blank\">GBTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324112-crypto-selloff-resumes-nordea-bank-bans-taleb-fan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crypto selloff resumes, Nordea Bank bans, Taleb a fan</a></h4><ul><li>Bitcoin late last week nearly tumbled below $9K before bouncing to nearly $13K at one point over the weekend. It's back down to about $10.6K this morning. Ethereum, Litecoin, and nearly the entire alt universe are also sharply lower.</li><li>In news, <a href=\"https://www.bloomberg.com/news/articles/2018-01-22/nordea-bans-employees-from-trading-bitcoin-spokeswoman-says\" target=\"_blank\">Nordea Bank has </a>imposed a ban on cryptocurrency trading for its 30K+ employees, effective Feb. 28, noting the \"unregulated nature\" of the market.</li><li>Also of interest <a href=\"https://medium.com/opacity/bitcoin-1537e616a074\" target=\"_blank\">is an essay on</a> Bitcoin by Nassim Taleb: \"It fulfills the needs of the complex system, not because it is a cryptocurrency, but precisely because it has no owner, no authority that can decide on its fate.\"</li><li>Related tickers: <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>, <a href='https://seekingalpha.com/symbol/COIN' title='Winklevoss Bitcoin Trust ETF'>COIN</a>, <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>, <a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>, <a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>, <a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>, <a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a>, <a href='https://seekingalpha.com/symbol/BITCF' title='First Bitcoin Capital Corp.'>OTC:BITCF</a>, <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a>, <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>, <a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a>, <a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>, <a href='https://seekingalpha.com/symbol/MGTI' title='MGT Capital Investments, Inc.'>OTCQB:MGTI</a>, <a href='https://seekingalpha.com/symbol/BTLLF' title='Interbit Ltd.'>OTCPK:BTLLF</a> <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a>, <a href='https://seekingalpha.com/symbol/GAHC' title='Global Arena Holding, Inc.'>OTCPK:GAHC</a>, <a href='https://seekingalpha.com/symbol/ARSC' title='American Security Resources Corp.'>OTC:ARSC</a>, <a href='https://seekingalpha.com/symbol/USTC' title='USA Real Estate Holding Co'>OTCPK:USTC</a>, <a href='https://seekingalpha.com/symbol/BLKCF' title='Global Blockchain Technologies Corp.'>OTCPK:BLKCF</a>, <a href='https://seekingalpha.com/symbol/COINB' title='Coinbase'>COINB</a>, <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3324112\" data-linked=\"Crypto selloff resumes, Nordea Bank bans, Taleb a fan\" data-tweet=\"$GBTC $GBTC $COIN - Crypto selloff resumes, Nordea Bank bans, Taleb a fan https://seekingalpha.com/news/3324112-crypto-selloff-resumes-nordea-bank-bans-taleb-fan?source=tweet\" data-url=\"https://seekingalpha.com/news/3324112-crypto-selloff-resumes-nordea-bank-bans-taleb-fan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>63&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324110\" data-ts=\"1516630346\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324110-premarket-losers-of-9-05-1-22-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (1/22/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/VICL' title='Vical Incorporated'>VICL</a>&nbsp;<font color='red'>-28%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3324061-astellas-pharmas-dna-vaccine-candidate-flunks-late-stage-study-cmv-positive-hsct-patients\" target=\"_blank\">announcing</a> top-line results for Phase 3 trial of cytomegalovirus vaccine ASP0113 in hematopoietic stem cell transplant recipients.</li><li><a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a> <font color='red'>-26%</font>.</li><li><a href='https://seekingalpha.com/symbol/SANM' title='Sanmina Corp'>SANM</a> <font color='red'>-23%</font>.</li><li><a href='https://seekingalpha.com/symbol/HGT-OLD' title='Hugoton Royalty Trust'>HGT-OLD</a> <font color='red'>-21%</font>.</li><li><a href='https://seekingalpha.com/symbol/FORD' title='Forward Industries, Inc.'>FORD</a> <font color='red'>-12%</font>.</li><li><a href='https://seekingalpha.com/symbol/IDRA' title='Idera Pharmaceuticals, Inc.'>IDRA</a>&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3324099-biocryst-pharma-idera-pharma-tie-knot\" target=\"_blank\">announcing</a> merger with BioCryst Pharma.</li><li><a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3324110\" data-linked=\"Premarket Losers as of 9:05 am (1/22/2018)\" data-tweet=\"$BBI $RCON $SANM - Premarket Losers as of 9:05 am (1/22/2018) https://seekingalpha.com/news/3324110-premarket-losers-of-9-05-1-22-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3324110-premarket-losers-of-9-05-1-22-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324109\" data-ts=\"1516630296\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LKM\" target=\"_blank\">LKM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324109-nq-mobile-pursues-rebranding-around-smart-rides-to-link-motion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NQ Mobile pursues rebranding around smart rides, to Link Motion</a></h4><ul>   <li>NQ Mobile (NQ), <font color='green'>up 2.1%</font> premarket, has rolled out a <a href=\"https://seekingalpha.com/pr/17051897-nq-mobile-inc-announces-proposal-rebrand-change-name-link-motion-inc\" target=\"_blank\">name change and rebranding</a> around its repositioning as a smart car/smart ride company.</li>    <li>The company plans to change names to Link Motion Inc., and change its ticker from NQ to LKM.</li>    <li>It expects to hold an extraordinary general meeting to consider the move on Feb. 27 in Hong Kong, at 9 a.m. Beijing time.</li>    <li>The core product offering of its smart car platform, it says, is the Link Motion Carputer Platform. At CES it also announced its next-gen CarBrain platform, to power smart cars that will eventually link drivers and riders together to ease ride sharing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324109\" data-linked=\"NQ Mobile pursues rebranding around smart rides, to Link Motion\" data-tweet=\"$LKM - NQ Mobile pursues rebranding around smart rides, to Link Motion https://seekingalpha.com/news/3324109-nq-mobile-pursues-rebranding-around-smart-rides-to-link-motion?source=tweet\" data-url=\"https://seekingalpha.com/news/3324109-nq-mobile-pursues-rebranding-around-smart-rides-to-link-motion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324096\" data-ts=\"1516630107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARRY\" target=\"_blank\">ARRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324096-arrays-crc-triplet-therapy-continues-to-show-positive-effect-in-late-stage-study-shares-ahead\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Array&#39;s CRC triplet therapy continues to show positive effect in late-stage study; shares ahead 12% premarket</a></h4><ul><li>Array BioPharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a>) is up&nbsp;<font color='green'>12%</font>&nbsp;premarket on modest volume on the heels of its <a href=\"https://seekingalpha.com/pr/17051691-combination-encorafenib-binimetinib-cetuximab-demonstrated-8-month-median-progression-free\" target=\"_blank\">announcement </a>of updated results from a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02928224?titles=beacon&amp;spons=array+biopharma&amp;phase=2&amp;rank=1\" target=\"_blank\">BEACON CRC</a>, assessing the triplet combination of encorafenib, binimetinib and Eli Lilly's ERBITUX (cetuximab) in patients with BRAF-positive metastatic colorectal cancer &#40;CRC&#41;. The data were presented at the ASCO GU Symposium in San Francisco.</li><li>In CRC patients with the BRAF V600E mutation, estimated median progression-free survival &#40;PFS&#41; was 8 months. The confirmed overall response rate &#40;ORR&#41; was 48%, including three complete responders. The ORR was 62% (n=10/16) in patients who received only one prior line of therapy.</li><li>On the safety front, the most common Grade 3 (serious) or Grade 4 (life-threatening) adverse events (AEs) (30 subjects) were fatigue (13.3%), urinary tract infection (10.0%); elevated AST (enzyme biomarker for liver damage) (10.0%) and elevated CK (enzyme biomarker for damage to the heart, muscle or kidney) (10.0%). There were two discontinuations due to treatment-related AEs.</li><li>Enrollment is ongoing. According to ClinicalTrials.gov, the estimated completion date is July 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3324096\" data-linked=\"Array&#39;s CRC triplet therapy continues to show positive effect in late-stage study; shares ahead 12% premarket\" data-tweet=\"$ARRY - Array&#39;s CRC triplet therapy continues to show positive effect in late-stage study; shares ahead 12% premarket https://seekingalpha.com/news/3324096-arrays-crc-triplet-therapy-continues-to-show-positive-effect-in-late-stage-study-shares-ahead?source=tweet\" data-url=\"https://seekingalpha.com/news/3324096-arrays-crc-triplet-therapy-continues-to-show-positive-effect-in-late-stage-study-shares-ahead\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324106\" data-ts=\"1516629945\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYMC\" target=\"_blank\">SYMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324106-symantecminus-1_7-on-analyst-downgrade-citing-turbulence-ahead\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Symantec -1.7% on analyst downgrade citing turbulence ahead</a></h4><ul><li>        Credit Suisse <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Credit+Suisse+Downgrades+Symantec+%28SYMC%29+to+Neutral%3B+Meaningful+Risk+of+Turbulence+Ahead/13705804.html\" target=\"_blank\">downgrades</a> Symantec (NASDAQ:<a href='https://seekingalpha.com/symbol/SYMC' title='Symantec Corporation'>SYMC</a>) from Outperform to Neutral and lowers the price target by $6 to $30, which is a 9% upside on Friday&rsquo;s close.</li><li>               Analyst Brad Zelnick cites checks into over VARs that suggested a meaningful risk of turbulence.&nbsp;</li><li>               Symantec shares are&nbsp;<font color='red'>down 1.7%</font>&nbsp;premarket.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3324106\" data-linked=\"Symantec -1.7% on analyst downgrade citing turbulence ahead\" data-tweet=\"$SYMC $NLOK - Symantec -1.7% on analyst downgrade citing turbulence ahead https://seekingalpha.com/news/3324106-symantecminus-1_7-on-analyst-downgrade-citing-turbulence-ahead?source=tweet\" data-url=\"https://seekingalpha.com/news/3324106-symantecminus-1_7-on-analyst-downgrade-citing-turbulence-ahead\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324105\" data-ts=\"1516629899\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIG\" target=\"_blank\">AIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324105-buy-m-related-dip-in-aig-wells-fargo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buy the M&amp;A-related dip in AIG - Wells Fargo</a></h4><ul><li>Investors may fret over <a href='https://seekingalpha.com/symbol/AIG' title='American International Group Inc'>AIG</a>'s reinsurance exposure following its $5.6B deal to buy Validus Holdings (NYSE:<a href='https://seekingalpha.com/symbol/VR' title='Validus Holdings, Ltd.'>VR</a>), but, says analyst Elyse Greenspan, they should instead focus on earnings accretion post-purchase, and AIG's continued ample excess capital.</li><li>Given the sizable premium (<font color='green'>45%</font>), Greenspan doesn't expect a competing offer to be forthcoming.</li><li>Credit Suisse's Ryan Tunis, meanwhile, says the purchase could add $0.30-$0.40 to AIG EPS in 2019.</li><li>Other possible reinsurance targets could be on the rise today, including Arch Capital (NASDAQ:<a href='https://seekingalpha.com/symbol/ACGL' title='Arch Capital Group Ltd.'>ACGL</a>), Aspen Insurance (NYSE:<a href='https://seekingalpha.com/symbol/AHL' title='Aspen Insurance Holdings Limited'>AHL</a>), Everest Re (NYSE:<a href='https://seekingalpha.com/symbol/RE' title='Everest Re Group Ltd.'>RE</a>), Reinsurance Group (NYSE:<a href='https://seekingalpha.com/symbol/RNR' title='RenaissanceRe Holdings Ltd.'>RNR</a>), XL Holdings (NYSE:<a href='https://seekingalpha.com/symbol/XL' title='XL Group plc'>XL</a>), and Third Point (NYSE:<a href='https://seekingalpha.com/symbol/TPRE' title='Third Point Reinsurance'>TPRE</a>).</li><li><font color='red'>Down more than 2%</font>&nbsp;immediately following the deal announcement, AIG is now&nbsp;<font color='red'>lower by just 0.6%</font>.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3324057-aig-5_5b-deal-validus-holdings\" target=\"_blank\">AIG in $5.5B deal for Validus Holdings</a> (Jan. 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3324105\" data-linked=\"Buy the M&amp;A-related dip in AIG - Wells Fargo\" data-tweet=\"$AIG $AIG $VR - Buy the M&amp;A-related dip in AIG - Wells Fargo https://seekingalpha.com/news/3324105-buy-m-related-dip-in-aig-wells-fargo?source=tweet\" data-url=\"https://seekingalpha.com/news/3324105-buy-m-related-dip-in-aig-wells-fargo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324104\" data-ts=\"1516629874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324104-ge-open-below-16-bofa-merrill-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE could open below $16 as BofA Merrill downgrades</a></h4><ul>     <li>General Electric (NYSE:<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a>) <font color='red'>-1.6%</font>&nbsp;premarket and on track to open below $16/share - its lowest level since Dec. 1, 2011 - after BofA Merrill Lynch <a href=\"https://www.cnbc.com/2018/01/22/general-electric-is-falling-again-after-bank-of-america-downgrade-nears-16-a-share.html\" target=\"_blank\">downgrades</a> the stock to Neutral from Buy.</li>     <li>BofA says its outlook \"reflects lower earnings estimates, zero equity value assigned to GE Capital, and lower value assigned to GE Digital initiatives, as we don't see the market paying up for this optionality,\" and adds that GE likely will cut its 2018 outlook when it reports Q4 results this Wednesday.</li>     <li>GE shares <a href=\"https://seekingalpha.com/news/3323943-ge-slides-another-3-percent-deutsche-bank-says-may-need-raise-equity-capital\" target=\"_blank\">fell every day last week</a> after the company said it would take a $6.2B after-tax charge related to its GE Capital insurance portfolio.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324104\" data-linked=\"GE could open below $16 as BofA Merrill downgrades\" data-tweet=\"$GE - GE could open below $16 as BofA Merrill downgrades https://seekingalpha.com/news/3324104-ge-open-below-16-bofa-merrill-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3324104-ge-open-below-16-bofa-merrill-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>83&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324099\" data-ts=\"1516628958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCRX\" target=\"_blank\">BCRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324099-biocryst-pharma-and-idera-pharma-tie-knot\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioCryst Pharma and Idera Pharma tie the knot</a></h4><ul><li>BioCryst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/BCRX' title='BioCryst Pharmaceuticals, Inc.'>BCRX</a>) and Idera Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/IDRA' title='Idera Pharmaceuticals, Inc.'>IDRA</a>) have agreed to <a href=\"https://seekingalpha.com/pr/17052123-biocryst-pharmaceuticals-idera-pharmaceuticals-announce-merger-combine-capabilities-serve\" target=\"_blank\">merge</a>. The combined company, to be renamed at closing, will be led by Idera CEO Vincent Milano. BioCryst Chairman Robert Ingram will serve as Chairman. BioCryst CEO Jon Stonehouse will be serve as a board member.</li><li>Under the terms of the deal, each BioCryst share will be exchanged for 1/2 of a share of the new company stock while each Idera share will be exchanged for 1/5 of a new share. BCRX shareholders will own 51.6% of the combined organization and IDRA shareholders will own 48.4%.</li><li>Idera's Exton, PA headquarters will be the corporate base of the new company.</li><li>Management will host a conference call this morning at 10:00 am ET to discuss the tie-up.</li><li><strong>Update</strong>: Investors don't appear to have much enthusiasm for the deal. Idera is down&nbsp;<font color='red'>22%</font>&nbsp;on triple normal volume and BioCryst is down&nbsp;<font color='red'>8%</font>&nbsp;on more than double normal volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3324099\" data-linked=\"BioCryst Pharma and Idera Pharma tie the knot\" data-tweet=\"$BCRX $BCRX $IDRA - BioCryst Pharma and Idera Pharma tie the knot https://seekingalpha.com/news/3324099-biocryst-pharma-and-idera-pharma-tie-knot?source=tweet\" data-url=\"https://seekingalpha.com/news/3324099-biocryst-pharma-and-idera-pharma-tie-knot\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324095\" data-ts=\"1516628385\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCHYY\" target=\"_blank\">SCHYY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324095-bullish-call-on-macau-from-cicc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bullish call on Macau from CICC</a></h4><ul> <li>Chinese investment banking firm CICC expects Macau gaming revenue to rise 25% in Q1 off of strength from new properties and junket operations.</li> <li>CICC expects Sands China (<a href='https://seekingalpha.com/symbol/SCHYY' title='Sands China Ltd ADR'>OTCPK:SCHYY</a>, <a href='https://seekingalpha.com/symbol/SCHYF' title='Sands China Ltd'>OTCPK:SCHYF</a>, <a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a>) to take significant market share during the year and sees a strong year for Wynn Macau (<a href='https://seekingalpha.com/symbol/WYNMF' title='Wynn Macau Ltd.'>OTCPK:WYNMF</a>, <a href='https://seekingalpha.com/symbol/WYNMY' title='Wynn Macau Ltd. ADR'>OTCPK:WYNMY</a>, <a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>) as well. Galaxy Entertainment (<a href='https://seekingalpha.com/symbol/GXYEF' title='Galaxy Entertainment Group, Ltd.'>OTCPK:GXYEF</a>) is also rated at Buy.</li><li>In Hong Kong earlier today, Wynn Macau <font color='green'>shot up 3.18</font>% and Sands China was <font color='green'>up 4.13%</font>. Galaxy Entertainment broke <font color='green'>3.21% higher</font> and MGM China (<a href='https://seekingalpha.com/symbol/MCHVF' title='MGM China Holdings, Ltd.'>OTCPK:MCHVF</a>, <a href='https://seekingalpha.com/symbol/MCHVY' title='MGM China Holdings, Ltd. ADR'>OTCPK:MCHVY</a>, <a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a>) finished <font color='green'>up 1.44%</font> as it rode the sector rally.</li></ul><div class=\"tiny-share-widget\" data-id=\"3324095\" data-linked=\"Bullish call on Macau from CICC\" data-tweet=\"$SCHYY $SCHYY $SCHYF - Bullish call on Macau from CICC https://seekingalpha.com/news/3324095-bullish-call-on-macau-from-cicc?source=tweet\" data-url=\"https://seekingalpha.com/news/3324095-bullish-call-on-macau-from-cicc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324093\" data-ts=\"1516627956\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXN\" target=\"_blank\">TXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324093-jefferies-increases-texas-instruments-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies increases its Texas Instruments price target</a></h4><ul><li>        Jefferies <a href=\"https://www.streetinsider.com/Analyst+Comments/Texas+Instruments+%28TXN%29+PT+Raised+to+%24150+at+Jefferies%3B+Positioned+to+Benefit+from+Multiple+Secular+%26+Cyclical+Trends/13706388.html\" target=\"_blank\">maintains</a> its Buy rating for Texas Instruments (NYSE:<a href='https://seekingalpha.com/symbol/TXN' title='Texas Instruments Inc.'>TXN</a>) and raise the price target from $111 to $150.</li><li>                  Increase comes after firm added Texas Instruments to its &ldquo;Franchise Pick List.&rdquo;    </li><li>                  Texas Instruments shares are&nbsp;<font color='green'>up 0.9%</font>&nbsp;premarket.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3323717-texas-instruments-promotes-crutcher-next-president-ceo\" target=\"_blank\">Texas Instruments promotes Crutcher as next president/CEO</a> (Jan. 18)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3323741-texas-instruments-declares-0_62-dividend\" target=\"_blank\">Texas Instruments declares $0.62 dividend</a> (Jan. 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3324093\" data-linked=\"Jefferies increases its Texas Instruments price target\" data-tweet=\"$TXN - Jefferies increases its Texas Instruments price target https://seekingalpha.com/news/3324093-jefferies-increases-texas-instruments-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3324093-jefferies-increases-texas-instruments-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324092\" data-ts=\"1516627949\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324092-tevas-subcutaneously-administered-reslizumab-flunks-late-stage-asthma-study-shares-down-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva&#39;s subcutaneously administered reslizumab flunks late-stage asthma study; shares down 3% premarket</a></h4><ul><li>Teva Pharmaceutical Industries (NYSE:<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a>) slips&nbsp;<font color='red'>3%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/17051988-teva-announces-top-line-results-phase-iii-studies-subcutaneously-administered-reslizumab\" target=\"_blank\">announcement </a>that a <a href=\"https://clinicaltrials.gov/ct2/show/NCT02452190?term=NCT02452190&amp;rank=1\" target=\"_blank\">Phase 3 clinical tria</a>l assessing subcutaneously administered reslizumab failed to achieve the primary endpoint of reducing the frequency of clinical asthma exacerbations in patients with uncontrolled asthma and elevated (&gt;300/mcL) blood eosinophils.</li><li>A <a href=\"https://clinicaltrials.gov/ct2/show/NCT02501629?term=NCT02501629&amp;rank=1\" target=\"_blank\">Phase 3 claim-support study</a> evaluating subcutaneously reslizumab in patients with oral corticosteroid &#40;OCS&#41;-dependent asthma also failed to meet its primary endpoint of reducing the daily OCS dose.</li><li>The company says it continues to see a treatment effect with the intravenous formulation, branded as CINQAIR in the U.S. and CINQAERO in Europe.</li><li><strong>Update</strong>: Investors appear to be shrugging off any perceived negativity with the news. Shares are only down a fraction so far in the session.</li></ul><div class=\"tiny-share-widget\" data-id=\"3324092\" data-linked=\"Teva&#39;s subcutaneously administered reslizumab flunks late-stage asthma study; shares down 3% premarket\" data-tweet=\"$TEVA - Teva&#39;s subcutaneously administered reslizumab flunks late-stage asthma study; shares down 3% premarket https://seekingalpha.com/news/3324092-tevas-subcutaneously-administered-reslizumab-flunks-late-stage-asthma-study-shares-down-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3324092-tevas-subcutaneously-administered-reslizumab-flunks-late-stage-asthma-study-shares-down-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324089\" data-ts=\"1516627590\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUAN\" target=\"_blank\">NUAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324089-nuanceplus-8-on-prelim-q1-results-beat-prior-guidance-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nuance +8% on prelim Q1 results that beat prior guidance, consensus</a></h4><ul><li>        Nuance (NASDAQ:<a href='https://seekingalpha.com/symbol/NUAN' title='Nuance Communications, Inc.'>NUAN</a>) Communications <a href=\"https://seekingalpha.com/pr/17052045-nuance-provides-preliminary-first-quarter-fiscal-2018-results\" target=\"_blank\">announces</a> preliminary results for Q1 with non-GAAP revenues of $507M to $510M (consensus: $492.72M) and EPS from $0.26 to $0.27 (consensus: $0.22).</li><li>               The results come in higher than the previous guidance, primarily due to strength in the Healthcare, Automotive, and Imaging segments.&nbsp;</li><li>               Net new bookings expected up 10% year-over-year. Cash flow from operations expected at $85M.&nbsp;</li><li>               Nuance shares are&nbsp;<font color='green'>up 8%</font>&nbsp;premarket.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3324089\" data-linked=\"Nuance +8% on prelim Q1 results that beat prior guidance, consensus\" data-tweet=\"$NUAN - Nuance +8% on prelim Q1 results that beat prior guidance, consensus https://seekingalpha.com/news/3324089-nuanceplus-8-on-prelim-q1-results-beat-prior-guidance-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3324089-nuanceplus-8-on-prelim-q1-results-beat-prior-guidance-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324081\" data-ts=\"1516626784\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PETS\" target=\"_blank\">PETS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324081-petmed-express-q3-revenues-up-14-eps-up-83-shares-ahead-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PetMed Express Q3 revenues up 14%; EPS up 83%; shares ahead 7% premarket</a></h4><ul><li>PetMed Express (<a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a> <font color='green'>+5.3%</font>) <a href=\"https://seekingalpha.com/pr/17052055-petmed-express-d-b-1minus-800-petmeds-announces-third-quarter-financial-results-increased\" target=\"_blank\">Q3 results</a>: Revenues: $60.1M (+13.6%); Operating Income: $11.5M (+49.4%); Net Income: $9.1M (+89.6%); EPS: $0.44 (+83.3%); Quick Assets: $81M (+38.0%); CF Ops: $35.1M (+11.1%).</li><li>No guidance given.</li><li>Shares are up&nbsp;<font color='green'>7%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3324081\" data-linked=\"PetMed Express Q3 revenues up 14%; EPS up 83%; shares ahead 7% premarket\" data-tweet=\"$PETS - PetMed Express Q3 revenues up 14%; EPS up 83%; shares ahead 7% premarket https://seekingalpha.com/news/3324081-petmed-express-q3-revenues-up-14-eps-up-83-shares-ahead-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3324081-petmed-express-q3-revenues-up-14-eps-up-83-shares-ahead-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324080\" data-ts=\"1516626736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324080-u-s-steel-upgraded-citi-which-sees-steel-equities-moving-still-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel upgraded at Citi, which sees steel equities moving still higher</a></h4><ul>     <li>U.S. Steel (NYSE:<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a>) <font color='green'>+1.6%</font> premarket after Citigroup <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Citi+Upgrades+US+Steel+%28X%29+to+Neutral/13705852.html\" target=\"_blank\">upgrades</a> shares to Neutral from Sell with a $43 price target, raised from $22, as the firm predicts another leg higher for the steel group even after recent gains.</li>     <li>Citi cites the multi-year cycle of above-average utilization and profitability driven by continued supply-side discipline in flat steel and recovery in non-residential construction in long steel.</li>     <li>Citi sees steel prices rallying through $700/ton in Q1 before pulling back due to lower raw materials costs in China; the firm does not expect more than a short-term boost from Section 232 action.</li>     <li>Steel Dynamics (NASDAQ:<a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a>), Nucor (NYSE:<a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a>) and Commercial Metals (NYSE:<a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a>) are Citi's top picks in the group, and it anticipates further industry consolidation, with STLD the most likely buyer.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324080\" data-linked=\"U.S. Steel upgraded at Citi, which sees steel equities moving still higher\" data-tweet=\"$X $X $STLD - U.S. Steel upgraded at Citi, which sees steel equities moving still higher https://seekingalpha.com/news/3324080-u-s-steel-upgraded-citi-which-sees-steel-equities-moving-still-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3324080-u-s-steel-upgraded-citi-which-sees-steel-equities-moving-still-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324078\" data-ts=\"1516626612\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324078-pareteum-gains-on-expanded-blockchain-partnership\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum gains on expanded blockchain partnership</a></h4><ul><li>Pareteum (NYSEMKT:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) announces the addition of Airfox's Blockchain and AirToken platform to the Pareteum Global Cloud Service Platform.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17052016-pareteum-airfox-expand-blockchain-technology-partnership\" target=\"_blank\">Press Release</a></li><li>Shares&nbsp;<font color='green'>up 3%&nbsp;</font>premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3324078\" data-linked=\"Pareteum gains on expanded blockchain partnership\" data-tweet=\"$TEUM - Pareteum gains on expanded blockchain partnership https://seekingalpha.com/news/3324078-pareteum-gains-on-expanded-blockchain-partnership?source=tweet\" data-url=\"https://seekingalpha.com/news/3324078-pareteum-gains-on-expanded-blockchain-partnership\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3324070\" data-ts=\"1516625887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAL\" target=\"_blank\">HAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3324070-halliburtonplus-3-after-strong-q4-beat-optimistic-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Halliburton +3% after strong Q4 beat, optimistic outlook</a></h4><ul>     <li>Halliburton (NYSE:<a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a>)&nbsp;<font color='green'>+2.9%</font> premarket after comfortably beating <a href=\"https://seekingalpha.com/news/3324048-halliburton-beats-0_07-beats-revenue\" target=\"_blank\">Q4 earnings</a> expectations and posting a 48% revenue improvement from the prior-year quarter.</li>     <li>HAL, which <a href=\"https://www.reuters.com/article/us-halliburton-results/halliburton-beats-on-fourth-quarter-profit-makes-tax-provision-idUSKBN1FB1HL\" target=\"_blank\">makes ~55% of its revenue</a> from North American operations, says Q4 revenue rose to $5.9B, 9% better than Q3, with North American revenue totaling $3.4B, up 7% Q/Q.</li>     <li>Q4 completion and production revenue rose 8% Q/Q to $3.8B, with segment operating income gaining 5% to $552M, while drilling and evaluation revenue jumped 12% Q/Q to $2.1B, and operating income for the business surged 62% to $291M.</li>     <li>HAL took a $385M Q4 charge on its Venezuela operations following Schlumberger's (NYSE:<a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a>) $900M charge announced last week; HAL also recorded $882M in charges related to the recent tax law changes.</li>     <li>\"We are on the path to normalized margins in North America in 2018,&rdquo; says President and CEO Jeff Miller. \"Commodity prices are supportive of increasing activity in North America and I am encouraged by the increase in tender activity and the positive discussions we are having with our international customers.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3324070\" data-linked=\"Halliburton +3% after strong Q4 beat, optimistic outlook\" data-tweet=\"$HAL $HAL $SLB - Halliburton +3% after strong Q4 beat, optimistic outlook https://seekingalpha.com/news/3324070-halliburtonplus-3-after-strong-q4-beat-optimistic-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3324070-halliburtonplus-3-after-strong-q4-beat-optimistic-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}